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Abstract  
The organic-inorganic hybrids fabricated by the sol-gel method are intrinsic 
bioactive materials with extensive applications in bone tissue engineering. 
The brittleness and limited water uptake capacity of these monoliths, 
however, restrict their applications for engineering the soft tissues and their 
interfaces with bone. To address these challenges, a unique class of organic-
inorganic hybrid was developed in which polymer crosslinking ceased the 
over-condensation of a bioactive glass component and eradicated the 
formation of brittle structure. 
In this study, an organosilane-functionalized gelatin methacrylate (GelMA) 
was covalently bonded to a bioactive glass during the sol-gel process, and 
the condensation of silica networks was controlled by photocrosslinking of 
GelMA. The physicochemical properties and mechanical strength of these 
hybrid hydrogels were then tuned by the incorporation of secondary 
crosslinking agents such as poly(ethylene glycol diacrylate) (PEGDA). The 
resulting bioresorbable hydrogels displayed elastic properties with ultimate 
elastic compression strain above 0.2 (mm/mm) and tuneable compressive 
modulus in the range of 42-530 kPa. The swelling ratio of these hybrids, 
however, was suitable for tissue engineering applications. In addition to 
remarkable enhancement in the mechanical properties of gelatin-based 
hydrogels, their structural integrity was significantly increased. As an 
example, these hybrid hydrogels kept their structures for more than 28 days, 
and only 30% of gelatin was released during this period in simulated body 
fluid. The presence of homogeneously distributed bioactive glass in these 
hydrogels, moreover, promoted the precipitation of calcium phosphate 
particles as the main inorganic compositions of the bone extracellular 
matrix. The continuous increase of alkaline phosphatase activity of bone 
progenitor cells for at least 28 days post-culture confirmed the 
osteoconductive properties of these hybrid hydrogels. The in vivo mice-
subcutaneous implantation, moreover, confirmed the biocompatibility and 
bio-resorption of these hydrogels. A bioactive hydrogel with a gradient of 
Page | vii 
 
mineralisation was also fabricated to confirm the feasible application of 
these hybrid hydrogels in interface tissue engineering.  
In summary, an organic-inorganic hybrid was developed that has favourable 
swelling properties and higher mechanical strength compared to ceramic 
based scaffolds. These hybrids were also bioactive, cytocompatible and 
bioresorbable. These gelatin-bioactive glass hydrogels can be used for 
regeneration of bone defects. It can also be used for the fabrication of 
gradient bioactive hydrogels for enhancing the integration of soft to hard 
tissue interfaces such as ligament and tendon.  
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 Chapter 1. Introduction  
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Bone is a dynamic tissue with a unique capacity to heal and regenerate 
without leaving a scar [1]. In addition to these remarkable properties, bone 
mobilises the stored minerals on the metabolic demands, supports muscular 
contraction resulting in motion, withstands load bearing, and protects 
internal organs [2]. The significant alterations in the bone structure, 
therefore, can dramatically alter the body equilibrium and quality of life. 
The severe post-operation complications of current reconstructive surgeries 
include donor site morbidity, disease infection, and deficient supply [3, 4]. 
These restrictions induce the total economic burden of hundred millions of 
dollars on public health per annum. It is critical to developing a new 
approach to addressing these issues and minimising the risk of failure of 
current bone repair operations. This strategy promotes the proliferation of 
progenitor cells specifically in their interface with soft tissues. The potential 
of this approach has not yet been exploited, and this is the focus of this 
project. 
Bioactive glass is a class of ceramics, which regulates the metabolism of 
soft and hard tissues through stimulating the osteogenic differentiation [5-
7], enhancing the pro-angiogenesis of endothelial cells [8-10], and 
modulating the intercellular interactions [11-14]. Despite their particular 
biological behaviour, the intrinsic brittleness of bioactive glasses restricts 
their direct application in bone regeneration. Different compositions of 
bioactive glass and polymers with enhanced mechanical properties have 
been developed to mimic the structure of bone [15-17].  
The sol-gel method is superior to melt-quenching process for the 
preparation of polymer-bioactive glass hybrids. The intriguing benefits of 
the sol-gel method include the low reaction temperature [18], controllable 
kinetic of reaction [19], and convenience in modification of composition 
[20]. This technique composed of two main steps of hydrolysis and 
condensation followed by ageing and drying processes. In particular, the 
collagen-inorganic composite has been used for musculoskeletal tissue 
engineering, as these components comprise the chemical structure of bone 
[21, 22]. However, the limited mechanical properties of these composites 
may evoke severe clinical complications [23]. Gelatin is a disintegrated 
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derivative of collagen and possesses the intrinsic capacity to form a 
hydrogel through distinct methods. The formation of gelatin-bioactive glass 
composites is deemed to be a more favourable alternative for mimicking the 
bone structure [24, 25]. 
The heterogeneity of dissimilar phases, however, is the main associated 
drawback of these organic-inorganic composites [26]. The uniform 
distribution of bioactive glass within polymer phase is the main advantage 
of chemically modified organic-inorganic hybrids with enhanced bioactivity 
and physicochemical properties [27, 28]. In addition to their synergetic 
nature of hybridisation, cost-effectiveness and tuneable mechanical 
properties of these materials introduce them as proper candidates for bone 
regeneration. The complete condensation of the inorganic compound in 
these hybrids, however, carries out through drying and ageing steps and 
yields brittle structures [29]. The fabrications of two-dimensional monoliths 
with very limited water uptake capacity are their main drawbacks for hard-
to-soft interface tissue engineering [30].  
The aim of this study was to develop a unique structure for reconstruction of 
bone structure and its interface with soft tissues. It was hypothesised that the 
fabrication of an organic-inorganic hybrid with enhanced mechanical 
performance and high swelling ratio might promote the proliferation of bone 
progenitor cells. To achieve this objective, a covalently bonded hybrid of 
gelatin-bioactive glass was fabricated by a sol-gel process. It was 
hypothesised that the crosslinking of the organic component might control 
the condensation of the inorganic phase, prevent the formation of the brittle 
structure, and tune the physicochemical and mechanical properties of 
hybrid.  
This dissertation is comprised of 7 chapters. In Chapter 2, a review of the 
bone tissue engineering is provided. Different methods of polymer 
crosslinking, and the fabricated organic-inorganic hybrids for bone tissue 
engineering are also discussed in detail. The hypotheses of this project arose 
from the shortfalls of current bone tissue engineering are also explained. 
In Chapter 3, different methods for fabrication of organic-inorganic hybrid 
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hydrogels are presented. Various methods to assess the biological and 
physicochemical properties and mechanical performance of these hybrid 
hydrogels are also described. In Chapter 4, the effects of external stimuli 
and polymer-crosslinking on the physical status and brittleness of 
interpenetrated hybrids are presented. In Chapter 5, the impacts of 
organosilation and formation of covalently bonded gelatin-hybrid on the 
physicochemical properties of hydrogels are assessed. The effect of 
incubation media on the degradation profile of hybrid hydrogels is also 
investigated. In Chapter 6, the secondary polymer-crosslinking approach is 
used to form a bioconjugated hybrid hydrogel. The mechanical performance 
and degradation profiles of these hybrid hydrogels are discussed. The 
in vitro bioactivity and biocompatibility are also conducted to examine the 
proliferation of bone progenitor cells in these constructs. Finally, the 
biocompatibility and the biological properties of this class of hydrogels 
were evaluated by conducting in vivo mice implantation performed under an 
ethically approved protocol (2013/019A). The potential of these hybrid 
hydrogels for interface tissue engineering is also investigated. In Chapter 7, 
the overall conclusions and recommendations for the continuation of this 
project are presented. 
  
  
Chapter 2. An Overview to 
Bone Tissue Engineering 
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2.1 Introduction 
Bone is a dynamic, highly vascularised tissue with a unique capacity to heal 
and regenerate without leaving a scar [1]. In addition to these remarkable 
properties, bone mobilises the stored minerals on the metabolic demands, 
supports muscular contraction resulting in motion, withstands load bearing, 
and protects internal organs [2]. The significant alterations in the bone 
structure, therefore, can dramatically alter the body equilibrium and quality 
of life. Musculoskeletal defects due to congenital anomalies, skeletal 
diseases, sport and life-related traumas impose an economic burden of 
approximately one billion dollars per annum on the Australian economy, 
with 70% of the expenditure on long recovery period and hospitalisation 
services [31].  
The current treatment of bone fractures is replacement of the damaged tissue 
with different biological grafts from the patient (autograft) [4, 32] or 
cadaver (allograft) [33], and synthetic grafts [34]. Despite the intrinsic 
osteoconductivity and osteoinductivity of biological grafts, concern issues 
are associated with the risk of disease transfer, donor site morbidity, chronic 
pain, infection and increase of operative time and cost [3, 4]. Tissue 
engineering is considered as a new approach, which might remedy these 
shortfalls. In this chapter, the bone structure and current methods for 
substituting the bone fracture are reviewed. Moreover, the ongoing research 
on the development of bone tissue engineering is discussed in detail.  
2.2 Current Treatment Approaches for Bone Regeneration 
Bone possesses an intrinsic capacity for regeneration as a part of the repair 
process in response to injury, as well as during skeletal development or 
continuous remodelling throughout adult life [35]. Bone regeneration is 
comprised of a well-orchestrated series of biological events of bone 
induction and conduction, involving a number of cell types and intracellular 
and extracellular molecular signalling pathways [36, 37]. Prior to 
introducing the current treatment approaches for bone regeneration, it is of 
great importance to understand the chemical composition and cellular 
constitution of bone structure.  
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2.2.1 The Bone Structure 
Bone is constructed from cells and an extracellular matrix (ECM). The 
cellular architecture of bone is predominantly comprised of osteoblasts [38], 
osteocytes, osteoclasts [39], and mesenchymal stem cells (MSC) [40] that 
differentiate into committed progenitors of osteoblasts, osteoclasts and other 
cells [41]. Osteoblast cells are found at the active sites of bone formation 
and synthesise the non-mineralised organic matrix called osteoid. The 
osteoid is comprised of collagen, glycoproteins, glycosaminoglycans, and 
bone morphogenetic proteins (BMP) to participate in the mineralisation 
process. Osteocytes are the most abundant cell population on the bone that 
are terminally differentiated osteoblasts [42]. Osteocytes have significant 
impacts on the bone performance by regulating the ECM maintenance and 
calcium homoeostasis and initiating of the remodelling cascade [43]. 
Finally, osteoclasts are the bone resorbing cells, which keep bone healthy 
and new through remodelling and renewal processes [44]. 
The bone extracellular matrix is particularly mineralised. Inorganic 
compounds such as calcium phosphates comprise 65% of ECM, and the rest 
is fabricated from organic components. Collagen is the main organic 
component that combines to other glycoproteins and glycosaminoglycans to 
construct the osteoid and ECM and modulate the cellular activity and 
intercellular signalling [45]. The inorganic compounds, moreover, are found 
within and between the length of collagen fibres to improve their 
mechanical performances towards bending and compressive loads. 
Hydroxyapatite (HAp) is the most abundant calcium phosphate in bone 
structure that can combine with other materials such as carbonates, citrates, 
magnesium, fluorides and strontium [45]. The presences of these organic 
and inorganic components have significant impacts on the cellular 
constitution of bone. Magnesium has an important impact on the 
calcification process, bone fragility, and mineral metabolism [46]. While the 
presence of strontium promotes the bone growth and formation [47], zinc 
fosters the proliferation and differentiation of osteoblasts [48]. Potassium 
[49], sodium [50], and chlorine [51], moreover, possess a versatile nature in 
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the regulation of bone remodelling process. The significant alterations in the 
cellular constitution or chemical composition of bone, therefore, can 
dramatically alter the body equilibrium and quality of life. The severe bone 
fracture cannot regenerate through bone remodelling process. The surgical 
treatment, therefore, is the only clinical treatment to remedy these shortfalls.  
2.2.2 Clinical Treatments for Bone Repair 
Different biological grafts including autografts and allografts have been 
transplanted to repair the injured or damaged bone. The intrinsic 
biocompatibility and non-immunogenicity of autologous grafts promote 
their applications as the gold standard for bone grafts [52]. Despite the 
promising osteoinductivity, osteogenesis, and osteoconductivity of 
autografts, they are associated with some issues and complications. Donor 
side morbidity, chronic pain, possible immunogenicity, and an increase of 
operative time and cost are some examples of these complications [53]. The 
size limitation, moreover, restricts the application of autografts while the 
defect site requires a larger volume of bone [54]. 
Allografts represent the second most common bone-grafting technique by 
transplanting donor bone tissue, often from a cadaver [55, 56]. Allogeneic 
bone is a cytocompatible tissue, which is available in various sizes 
depending on the host-site requirements [57, 58]. The high risk of 
immunogenicity and transmission of infections, the reduced 
osteoconductivity, and the substantial cost issues, however, are limiting 
factors on clinical application of allografts [59, 60]. Despite the significant 
impacts of current transplantation methods on bone regeneration, they 
suffered from some intrinsic complications including low osteoinductive 
and angiogenic potencies, limited availability, and a high donor side 
morbidity. Tissue engineering is considered as a new approach, which might 
remedy these shortfalls. 
2.3 Bone Tissue Engineering 
Tissue engineering integrates osteoprogenitor cells, biological and 
mechanical stimulations, and scaffolds to regenerate the bone structure [61-
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64]. The scaffold is a temporary structure and logistic template for tissue 
engineering. It serves as “informational templates” to the cells, by 
patterning implementation, binding ligands and sustained releasing of 
cytokines [65]. The ideal scaffold has three dimensional (3D) structure 
composed of biocompatible materials with a controllable degradation 
profile. The degradation rate needs to be commensurate with neotissue 
formation while still maintaining the mechanical properties over the 
degradation period and tissue regeneration. The presence of interconnected 
pores with an average diameter with the range of 50 to 200 µm is critical for 
bone repair [66]. This interconnectivity acquires sufficient mass transfer 
feature for nutrients and waste, which provides an appropriate environment 
for cell adhesion, proliferation, and differentiation [67-69].  
The selection of a proper material to fabricate a scaffold is the most 
important factor towards the engineering the bone. While the ceramics 
represent intrinsic osteoinductive and osteoconductive behaviours, their 
limited degradation profiles restrict their applications in bone tissue 
engineering. The application of natural and synthetic polymers with 
controllable degradation profiles, moreover, is limited due to their lack of 
bioactive characteristics. The modified bioactive polymers [70-72], 
biodegradable ceramics [73-76], and their organic-inorganic complexes [77, 
78], therefore, have been assessed to design a biomimetic scaffold for bone 
regeneration. Hydrogels, for instance, mimic the chemical composition of 
ECM due to their intrinsic biocompatibility and desirable physicochemical 
characteristics [79]. The shortfalls of hydrogels including low mechanical 
properties and fast degradation profiles must be overcome prior to their 
applications for bone tissue engineering [80]. In this session, an overview of 
biomaterials that have been used for bone regeneration was presented.  
2.3.1 Polymer-based Scaffold for Bone Tissue Engineering 
Collagen is the most abundant organic component in the bone structure [45]. 
The lack of osteoinductive and osteoconductive behaviour restricts the 
application of pure collagen for bone tissue engineering. The combination of 
bioactive compounds such as inorganic materials [81-83] or biological 
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motifs [84-86] to collagen-based scaffolds, for instance, is an attempt to 
mimic the bone structure. These scaffolds, however, possess insufficient 
mechanical properties due to difficult reproducing of collagen spatial 
conformation in osteon sites [45]. In addition to extensive application of 
collagen [87], other natural-based polymers including alginate [88-90], 
chitosan [91-93], gelatin [94-97], Gellan gum [98, 99], and silk [100-102] 
have been used to fabricate a biocompatible complex for bone tissue 
engineering.  
Synthetic polymers such as aliphatic polyesters and their copolymers were 
extensively used to fabricate a biodegradable scaffold incorporated with 
bioactive compounds for bone tissue engineering [103, 104]. Several 
attempts have been approached on the fabrication of 3D scaffolds from 
poly(lactic acid) (PLA) [105, 106], poly(lactic-co-glycolic acid) (PLGA) [6, 
107, 108], poly (ɛ-caprolactone) (PCL) [109-112], poly anhydrides [113], 
and poly(phosphazenes) [114]. The incorporation of osteoconductive 
components in these polymers promoted their application in bone tissue 
engineering. Hydrogels fabricated from synthetic, or natural polymers 
possess superior impacts on tissue engineering. The biodegradable 
hydrogels mimic the chemical composition of ECM due to their intrinsic 
biocompatibility and desirable physicochemical characteristics, which guide 
the spatially complex multicellular processes of tissue regeneration [115]. 
The intermolecular interactions between polymer chains have a significant 
effect on their physicochemical and mechanical properties. These 
interactions, as well as chemical stimulus, can form a 3D network by 
crosslinking of polymer chains. The physicochemical associations including 
ionic interactions [116-120], crystallisation [121-124], and self-assembly 
[125-133] induce gelation of polymers upon hydrogen bonding, and van der 
Waals and π- π intermolecular interactions. The limiting factors of these 
physically crosslinked hydrogels are their weak mechanical properties, fast 
dissociation in the physiological condition, and the lack of interconnected 
porosity within their structures [134]. The formation of a covalent bond 
between polymer chains, however, leads to the hydrogels with superior 
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mechanical strength and enhanced degradation profile. In the next session, 
different chemical and photocrosslinking methods to fabricate a hydrogel 
are discussed, briefly  
2.3.2 Hydrogel Fabrication via Chemical Crosslinking  
Chemical stimulus induces gelation of the polymeric solution by forming 
chemical changes in the molecular structure of precursors or by the 
fabrication of covalent bonds in their polymeric systems [135]. These 
covalent interactions include Michael addition, Schiff and click reactions, 
redox-polymerisation, disulphide formation, and enzymatic- or 
photocrosslinking. The schematic of these chemical reactions is shown in 
Scheme  2-1. 
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Scheme  2-1 Scheme of chemical reactions used for covalent crosslinking of polymers 
[136]. 
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Michael Addition 
Michael addition is the 1, 4- addition of nucleophiles to α,β-unsaturated 
electrophiles. The nucleophile components comprised from thiol- and 
amine-functionalised macromeres, whereas ketones or esters with vinyl 
sulfone-, acrylate-, methacrylate-, or methacrylamide functional groups 
have been used as electrophiles [136]. The high efficacy of this gelation 
scheme under aqueous physiological conditions without the formation of 
any side products favours this method for biomedical applications. The 
nucleophilic derivatives of natural polymers including dextran [137], gelatin 
[138-140], hyaluronic acid [141-144] and collagen [145], and synthetic 
polymer such as poly(ethylene glycol) (PEG) [146-148] have been used to 
form a biocompatible hydrogel for tissue engineering or drug delivery 
applications. The thiolated gelatin, for instance, formed a hydrogel in the 
presence of acrylate-derivative of PEG as a crosslinking agent [140]. The 
encapsulation of fibroblasts within these hydrogels enhanced their 
cytoplasmic spreading and proliferation. The nucleophilic derivatives PEG 
were also used to fabricate biocompatible hydrogels for encapsulation of 
biological active agents [149, 150] and chondrocyte cells [151]. Despite the 
fast hydrogel formation using Michael addition, the complex mechanism of 
synthesis using toxic components, and the insufficient mechanical properties 
and degradation profile of resulting hydrogels limited their applications for 
bone tissue engineering. 
Schiff’s Base Reaction 
A Schiff’s base crosslinking is a condensation of an amine functional group 
by an aldehyde group without the use of any catalysts. Glutaraldehyde, for 
instance, has extensively used to crosslink different natural and synthetic 
polymers. Collagen [152, 153], chitosan [154, 155], and gelatin [156], for 
instance, have been crosslinked by glutaraldehyde to form a hydrogel for 
engineering different tissues. The associated problems with a high 
concentration of glutaraldehyde such as heterogeneous crosslinking and the 
intrinsic cytotoxicity have been overcome at low concentration [157]. The 
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chemical modification of polysaccharides with oxidative agents such as 
sodium periodate (NaIO4) to create aldehyde groups is another approach to 
forming a hydrogel with amine-functionalised polymers. The oxidisation of 
dextran [158, 159], alginate [160], and hyaluronic acid [161] formed an 
in situ hydrogel with amine groups of gelatin and chitosan. The external 
stimuli including pH and ionic strength of the solution, and degree of 
oxidisation had a significant impact on gelation rate of these hydrogels 
[162]. Despite the high gelation efficiency of Schiff base in physiological 
condition [163], the in vivo performances of these hydrogels may be altered 
due to the inflammation and calcification of surrounded tissue upon the 
reaction with aldehyde functional groups [164].  
Genipin is a natural-based crosslinking agent showing 10,000 times less 
cytotoxic than glutaraldehyde [165]. The mechanism of protein-crosslinking 
with genipin is not entirely understood [166]. However, it is known that the 
free amine groups of the peptide such as Arg-Gly-Asp (RGD) interact with 
genipin to form a heterocyclic structure [167]. The genipin-crosslinking, 
moreover, is a pH-dependant mechanism that undergoes ring-opening 
polymerisation under basic conditions [168]. At acidic or neutral conditions, 
however, genipin directly reacts with the primary amine functional groups. 
Different natural polymers such as chitosan [169, 170], collagen [171, 172] 
and gelatin [173, 174] have been crosslinked by genipin for tissue 
engineering application. 
Disulphide Formation 
An in situ hydrogel forms upon the formation of disulphide bonds between 
intermolecular chains of polymers with thiol functional groups [175]. The 
crosslinking proceeds through the oxidation of thiol groups at pH above 5 in 
the presence of oxidising agent [176]. The reversible hydrogel of thiolated 
hyaluronic acid, for instance, was fabricated through disulphide crosslinking 
approach in physiological condition [177, 178]. The physicochemical 
properties of hydrogels fabricated through this scheme are highly dependent 
upon the nature of the polymer backbone [179], the degree of oxidisation 
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[180] and the chemistry of oxidising agent [181]. Despite the controllable 
degradation profile of these hydrogels, the complex mechanism of 
crosslinking and the presence of oxidising agent restrict the practical 
application of these hydrogels. 
Click Reaction 
A click reaction is the cycloaddition of azide and alkyne to form a triazole 
ring in the presence of Cu(I) as a catalyst. This approach has a vast range of 
application in biomedical engineering due to its rapid proceeding and high 
conversion rate without side products in physiological condition [182, 183]. 
The orthogonal nature of this strategy, moreover, ensures the absence of 
cross-reactions with other functional groups [134, 184]. Different synthetic 
and natural polymers such as poly(vinyl alcohol) [185], PEG [186-188], 
polypeptide [189], hyaluronic acid [190], and gelatin [191] were converted 
to their azide or acetylene derivatives to form a hydrogel via click reaction. 
The toxicity of the catalyst renders such reactions undesirable for in situ cell 
encapsulation. The residual Cu (I) trapped in the gels during the synthesis 
needs to be extracted thoroughly before the gels can be used for cell culture. 
A copper-free click reaction, therefore, has been developed using 
cyclooctyne derivatives [192]. In this approach, azide and cyclooctyne 
derivatives undergo rapid cycloaddition reactions under physiological 
conditions in the absence of auxiliary reagents [193-195]. A hydrogel with 
enhanced physicochemical and mechanical properties and tuneable gelation 
was fabricated from the functionalised chitosan-PEG complex using copper-
free click chemistry. Despite the possible application of these hydrogels as 
injectable biomaterials [196], the copper-free click chemistry is infancy, and 
further research is required to understand the biological effects of this 
method at the insertion site. 
Redox-polymerisation 
The release of free radicals from redox reactions in an aqueous solution can 
trigger the crosslinking of polymers with acrylate or methacrylate functional 
groups. This approach is initiated by the addition of ammonium persulphate 
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(APS) to tetramethylethylenediamine (TMEDA) [197] or ascorbic acid 
(AA) solutions [198]. The redox-polymerisation has been used to fabricate 
biocompatible hydrogels with enhanced mechanical properties and 
degradation profiles. For instance, synthetic polymers such as 
poly(propylene fumarate-co-ethylene glycol) [199], oligo(poly(ethylene 
glycol)fumarate) [200] and poly(lactic-ethylene oxide fumarate) [201], and 
acrylate-derivatives of natural polymers including dextran [202] and 
chitosan [203] formed biodegradable hydrogels for different biomedical 
applications. Moreover, the encapsulation of cytocompatible moieties such 
as growth factors [204], drugs [205], and cells [206] within their 3D 
structures extensively enhanced their biomedical application. Despite the 
biologically benign process of redox-polymerisation, the residue of free 
radical ions is an issue for biomedical applications. 
Enzymatic-crosslinking 
The selective cleavage or ligation of enzymes to a particular bond promotes 
their application as a crosslinking agent without interfering with other 
chemical moieties of the polymer. Different enzymatic reactions including 
horseradish peroxidase [207], transglutaminase [208], phosphatase [209], 
tyrosinase [210], themolysin [211], α-galactosidase [212], and esterase 
[213] have been used to form a hydrogel. Horseradish peroxidase (HRP) is 
extensively used to prepare an enzymatic hydrogel. A solution of HRP in 
H2O2 is added to an aqueous solution of polymers containing tyrosine or L-
3,4-dihydroxyphenylalanine (DOPA) to catalyse their oxidative coupling 
reactions. The peptide-functionalised derivatives of PEG [214], chitosan 
[215], dextran [207], gelatin [216], heparin [217], and hyaluronic acid [218] 
were used for the substrate of HRP. The incorporation of HRP/H2O2 to 
these solutions rapidly formed a hydrogel by oxidative coupling of their 
peptides. A tyrosine-modified solution of hyaluronic acid, for instance, was 
subcutaneously injected into the rats to form an enzymatically crosslinked 
hydrogel in less than 20 s [219]. The concentration of hydrogen peroxide 
and enzyme have significant impacts on the gelation time and 
physicochemical and mechanical properties of these hydrogels [220].  
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Transglutaminase (TG) is another enzyme that catalyses a calcium-
dependent acyl transfer reaction between amines and ɣ-glutaminyl 
functional groups. The presence of polypeptides containing lysine and 
polymers with glutamine groups is vital for these reactions [221]. A 
glutamine-modified PEG, for instance, was enzymatically crosslinked with 
poly(lysine-co-phenylalanine) in an aqueous solution of TG [222]. Gelatin 
is a biopolymer with a sequence of lysine residues and glutamine functional 
groups. A cell-encapsulated hydrogel, therefore, was fabricated by 
enzymatic crosslinking of gelatin in the presence of TG [223]. Despite the 
high selectivity of this crosslinking method, the presence of unreacted 
enzymes acts as an impurity and has adverse impacts on biocompatibility of 
the system through denaturing of hydrogel as well as the encapsulated 
compound [136]. 
Photocrosslinking 
Photocrosslinking provides some economic advantages over other chemical 
crosslinking methods including fast hydrogel formation in physiological 
condition, organic-solvent free formulation as well as the low cost [224]. 
Typically, an aqueous solution of macromer goes through short exposure of 
visible light [225, 226], ultraviolet (UV) [227, 228], or laser [229, 230] in 
the presence of a light-sensitive component called as photoinitiator. The 
efficiency of this approach is dependent upon the nature of photoinitiator, 
beam wavelength, and the macromer. The chemistry of photoinitiator 
determined the specific parameters of the reaction such as the rate, spectral 
sensitivity, light resistance, and the stability of materials under storage 
conditions [224]. Two types of photoinitiators exist to crosslink the 
macromer. The first type of photoinitiators generates the active radicals with 
the capacity of initiating the radical polymerisation. The α-
hydroxyalkylphenones derivatives such as 4-(2-hydroxyethylethoxy)-
phenyl–(2-hydroxy-2-methyl propyl) ketone (Irgacure® 2959) are extremely 
reactive and form benzoyl and alkyl radicals upon UV-irradiation. The 
second type of photoinitiators, however, requires a tertiary amine molecule 
as a co-initiator to abstract the hydrogen. Eosin, for instance, reacts with 
Page | 18 
 
triethanolamine as a co-initiator to form intermediary species. The photo-
initiation continues with an electron and hydrogen transfer resulting in the 
radical formation [231].  
Different natural and synthetic polymers have been converted to their 
acrylate-derivatives to form a photocrosslinkable hydrogel. Natural 
polymers such as alginate [232], chitosan [233], chondroitin sulphate [234], 
gelatin [235], heparin [236], hyaluronic acid [237], starch [238], and 
tropoelastin [239, 240] were widely used to fabricate a photocrosslinkable 
hydrogel. Methacrylated hyaluronic acid, for instance, forms a 
photocrosslinkable hydrogel under laser [229] or UV irradiation [237]. The 
laser crosslinking process was initiated in the presence of 
eosin/triethanolamine using an argon laser at 514 nm. Upon laser exposure, 
eosin is excited to the triplet state, and triethanolamine donates an electron 
to generate a radical anion of eosin and a radical cation of ethanolamine. 
These free radicals polymerise an aqueous solution of functionalised-
hyaluronic acid [229].  
The bioprintable hydrogel, on the other hand, was designed by UV-
irradiation of methacrylate-derivatives of gelatin and hyaluronic acid in the 
presence of acetophenone as a photoinitiator [237]. The various cell-laden 
structures for engineering the different tissues were fabricated from the 
methacrylated gelatin (GelMA) [241-243]. The free amine groups of gelatin 
were converted to their methacrylate derivatives to form a hydrogel in the 
presence of Irgacure as a photoinitiator [244-246]. Despite the promising 
biological behaviour of these naturally derived hydrogels, their compressive 
modulus was inferior and varied in the range of 0.5 kPa to 100 kPa [230, 
234, 247]. 
PEG-based polymers were also modified to their acrylate derivatives to 
form a photocrosslinkable hydrogel. Despite the favourable 
physicochemical and mechanical properties of these hydrogels [248-250], 
the lack of cell motifs in these hydrogels restricts their biomedical 
applications. This drawback was addressed by incorporation of polypeptides 
such as RGD [251, 252], growth factors [253], and naturally derived 
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polymers [254-257]. A cell-laden hydrogel, for instance, was fabricated by 
photocrosslinking of an MSC-suspended solution of hyaluronic acid and 
PEG diacrylate (PEGDA) in the presence of transforming growth factor 
(TGF-β3) [253]. After subcutaneous injection of the suspension into mice, 
their skin was exposed to UV radiation to facilitate in situ hydrogel 
formation. The stem cells were chondrogenically differentiated and 
expressed cartilage-specific genes over 3-weeks of implantation. A micro-
patterned hydrogel, moreover, was fabricated upon the photocrosslinking of 
an aqueous solution of PLEOF-PEGDA incorporated with GelMA [254]. 
While the physical stability and mechanical properties of hydrogels relied 
on the synthetic polymers, the presence of GelMA promoted the 
proliferation of encapsulated osteoblasts. Despite the extensive 
advantageous of photocrosslinking for hydrogel formation and micro-
patterning, UV-induced polymerisation might have negative impacts on the 
encapsulated cells, drugs or growth factors [258]. The proper selection of 
photoinitiator and beam wavelength could minimise these drawbacks. 
2.4 Ceramic Scaffolds for Bone Tissue Engineering 
Bioceramic is a solid compound comprised of inorganic and non-metallic 
elements formed by the application of heat and pressure [259]. The intrinsic 
osteoconductive behaviours and high mechanical strength of these class of 
materials introduce them as a proper candidate for tissue engineering [260]. 
The slow degradability of these materials and their osteoinductivity, 
however, must be modified prior to their application as a bone scaffold. The 
fabrication of porous structures with interconnected pores [261] or the 
incorporation of polymers into bioceramic structure [262], for instance, are 
some attempts to enhance their degradation profile. The osteoinductivity of 
bioceramics, moreover, is modified using calcium phosphate ceramics. 
These bioceramics demonstrate unique biological interactions towards their 
physiological environment upon inducing of calcification and promoting the 
osteoinductivity [54]. 
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2.4.1 Calcium Phosphate Ceramics 
Calcium phosphate ceramics (CPCs) is extensively used in the forms of 
tricalcium phosphate (β-TCP, Ca3[PO4]2) and hydroxyapatite (HAp, 
Ca10[PO4]6[OH]2) [263]. Despite the similar elemental composition of HAp 
and β-TCP, their physicochemical properties are significantly different. β-
TCP, for instance, exhibits an adversely high dissolution rate with an 
immunologic response [264]. On the other hand, HAp possesses a 
crystalline structure with limited in vivo degradation profile [265]. This 
variation is a result of dissimilarity in the density and crystalline structure of 
HAp and β-TCP due to their different fabrication process.  
The sintering process of CPCs carries out in the range of 800°C to 1500°C 
and the partial pressure of water in this atmosphere has a significant impact 
on the formation of final ceramics. While the β-TCP is fabricated upon 
thermal decomposition, the presence of water promotes the rate of phase 
transition of β-TCP to HAp [266, 267]. The wet fabrication process such as 
precipitation, hydrothermal and hydrolysis of other CPCs are used to 
fabricate HAp [268]. Despite the attractive feature of these materials, their 
clinical applications were limited to non-load bearing applications due to 
their intrinsic brittleness [269]. Different approaches including the ionic-
substitution [270], and the formation of polymer-ceramic composites [17, 
271] have been attempted to overcome these shortfalls. 
The mineral component of bone is similar to HAp but contains other ions in 
the composition that play a significant role in the biological behaviour of 
bone. The ionic incorporation into the structure of β-TCP and HAp, 
therefore, can regulate their lattice structure, microstructure, crystallinity, 
and dissolution rate of CaPs [272, 273]. The ionic incorporation of fluoride 
[274], magnesium [275], manganese [276], silver [277], strontium [278], 
and zinc [279], within CPCs had significant impacts on the biological 
behaviour of these bioceramics. The incorporation of silicon into nano-
calcium phosphates, for instance, facilitate the adhesion, spreading, growth 
and proliferation of osteoblasts on these ceramic-based scaffolds [280]. 
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2.4.2 Bioactive glass 
Bioactive glass (BG) is a class of ceramics, which regulates tissue 
metabolism through stimulating the osteogenic differentiation [5-7], 
enhancing the pro-angiogenesis of endothelial cells [8-10], and modulating 
the intracellular interactions [11-14]. Silicon as the essential component of 
BG attributes to the collagen formation [281] and calcification of bone 
tissue [282]. The incorporation of other ionic components such as calcium 
[283, 284], phosphorous [20, 285], strontium [286, 287], and borate [288, 
289] enhances the therapeutic properties of BG towards a particular 
biological response [290]. 
Bioactive glass is fabricated through the melt-quenching process [291-294] 
or sol-gel method [295-298]. In the melt-quenching process, the melted 
mixture of alkali or alkali earth salts in a predetermined composition is 
quenched to form a glass with a disordered structure [299]. This structure is 
further milled to produce a BG with desired particle size [300]. Despite the 
basic nature of the melt-quenching process, the high processing temperature, 
difficult shaping process, and the high risk of contamination may have 
adverse impacts on the composition and bioactivity of BG. These issues 
could overcome by the sol-gel method, which comprised from hydrolysis 
and condensation reactions. The mechanism of the sol-gel method would be 
discussed at the end of this chapter. 
2.4.3 Modification of Ceramic Structure by Polymers 
The incorporation of polymeric components in the structure of bioceramics 
can enhance their mechanical properties and degradation profile. Several 
attempts such as foam replica method [301, 302] and polymer-ceramic 
composite formation [303-305] have been attempted to design a scaffold for 
bone tissue engineering.  
Foam replica method is based on the impregnation of an aqueous suspension 
of bioceramic in porous polymeric foam. After totally filling the pores, the 
excess suspension is removed from the impregnated foam upon passing 
through a roller or centrifuging [306]. The foam is then carefully heated at 
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temperatures between 300ºC and 800ºC for slow decomposition and 
diffusion into polymeric template [307]. The porous scaffold is then 
densified upon sintering at temperatures ranging from 1100ºC to 1700ºC to 
produce macro-porous structures with an interconnected pores [308, 309]. 
The mechanical strength of these structures, however, can be degraded by 
the formation of cracked struts during the decomposition of the foam [301]. 
Nanocomposite hydrogels are defined as an organic-inorganic composites 
crosslinked in the presence of nanoparticles [310-314]. The presence of the 
inorganic compound in theses hydrogels enhance their physicochemical and 
biological behaviours [315]. An injectable nanocomposite hydrogel, for 
instance, was fabricated from PEG and nano-HAp [316]. This composite 
possessed elastic mechanical properties with promoted biological behaviour. 
Despite the extensive application of polymer-ceramic composites, the 
heterogeneous distribution of ceramic nanoparticles within the polymer 
network may have a negative impact on their in vivo bone tissue engineering 
application. Fabrication of organic-inorganic hybrid could enhance the 
homogeneous distribution of mineralised phases within the polymeric 
scaffold.  
2.5 Organic-Inorganic Hybrids 
The first classification of organic-inorganic hybrid materials dates back to 
the beginning of the 1990s when Novak introduced them in five distinct 
types [317]. The chemical structure of the organic component (i.e., polymer 
or monomer) and the chemical interaction between organic and inorganic 
phases are their main distinctive criteria. The first class of organic-inorganic 
hybrid comprises from embedding a polymer within an inorganic precursor. 
In these hybrids, an interpenetrated network of organic-inorganic 
compounds is formed via intermolecular forces such as van der Waals, 
whereas, in type II, a polymeric is covalently bonded to the inorganic 
network structure. 
The second class of hybrids is fabricated from the simultaneous 
interpenetration of organic monomers within the inorganic precursors. The 
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presence of covalent bond between these two phases converts type III 
materials to type IV hybrid [318-324]. The last type of hybrids, also known 
as a non-shrinking material, is fabricated through mutual polymerisation of 
organic-inorganic precursors in the presence of polymerisable catalysts and 
solvents [325, 326]. The presence of the catalyst, organic solvents, and 
monomers for these simultaneously formed hybrids are their major burdens 
for their biomedical applications.  
The organic-inorganic hybrids possess broad biomedical applications. 
Scaffold fabrication [259, 327], coating the surface of implants [328-330], 
constructing the optical biosensor [331, 332], and encapsulation of 
biological components [333-338] are few examples of their applications in 
biomedical engineering. These biomaterials are commonly fabricated from 
type I or II hybrids through the sol-gel method. The presence of covalent 
bond between components has a significant effect on their properties. The 
applications of these hybrids (type I and II) in bone tissue engineering are 
discussed in the following sections. In addition, the mechanism of the sol-
gel method would be discussed at the end of this chapter. 
2.5.1 The Interpenetration of Polymer within Inorganic Network 
Type I hybrid is generated from the interpenetration of a polymer within an 
inorganic network using the sol-gel method. These dissimilar phases 
fabricate macroscopically uniform materials while their nanostructures are 
entirely separated [339]. It is crucial to optimise the conditions of the 
fabrication process to prevent the polymer phase separation during gel 
formation and drying processes. The selection of a suitable solvent for 
dissolving both polymer and inorganic phase is a crucial in the formation of 
hybrids to eradicate phase separation and insufficient mechanical integrity 
[340]. 
Solvents such as water, alcohols, hydrochloric acid, and formic acid are 
used to prepare organic-inorganic hybrids. The presence of liberated 
methanol or ethanol during the gel formation, however, can modify the 
solvent properties. A polymer that is initially soluble in the solvent may 
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precipitate at later stages of gel formation due to the bulk conversion of 
solvent from polar aprotic to polar protic [317]. Poly(vinyl pyrrolidone) 
(PVP), for instance, formed a homogenous solution with formic acid and 
tetraethyl orthosilicate (TEOS) mixture. The irreversible polymer 
precipitation, however, occurred upon release of ethanol into the reaction 
prior to the condensation of the silica network [317]. The homogenous 
hybrid of PVP-TEOS, on the other hand, was formed in the presence of 
isopropyl alcohol [341] as a solvent. The chemical structure of the polymer 
and its feasible interaction with alcohols, therefore, is critical. 
The chemical structure of the organic phase is a critical factor in the 
formation of the type I hybrids. The presence of basic functional groups, 
such as amine and pyridine, makes the organic phase soluble in the acidic 
catalysed solution of silica during the condensation and drying processes 
[342]. On the other hand, the presence of hydrogen bond acceptor groups in 
the backbone of the polymer enhances the formation of van der Waals 
interactions between polymer and inorganic phase [343]. Different natural 
and synthetic polymers were incorporated into bioactive glass (BG) 
precursors to form a hybrid are discussed in detail. 
Interpenetration of Natural Polymers within the Inorganic Network 
The first application of the interpenetrated network of organic-inorganic 
compounds in tissue engineering dated back to the end of the 1990s. An 
ethanol-catalysed silica solution was added to an acidic solution of chitosan 
to form an artificial skin [344]. The presence of the silica network had 
significant effects on oxygen permeation and also a proliferation of L929 
fibroblasts on these membranes [345]. These outcomes encouraged 
researchers to develop a protein-silica complex for tissue engineering 
applications. For instance, an interpenetrated network of silica and collagen 
was prepared for bone tissue engineering [346-348]. The interpenetrated 
hybrid with 60 wt% collagen, for instance, displayed a splitting tensile 
strength of 20 MPa. These monoliths, however, demonstrated brittle 
structures and broke at 6% compression strain [348]. Gelatin as a 
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disintegrated derivative of collagen is extensively used for fabricating of 
organic-inorganic complex [24, 25]. The gelatin-silica microgels, for 
instance, was fabricated to protect the encapsulated cardiac side population 
cells within their structure [349]. The silica hybridisation significantly 
enhanced cell proliferation. These complexes with a young modulus of 
1.87 kPa, however, were not suitable for hard tissue engineering. 
Interpenetration of Synthetic Polymers within the Inorganic Network  
Synthetic polymers are the favourite class of materials due to their tuneable 
and predictable physicochemical and mechanical properties upon the 
modification of their functional groups [350]. The presence of siloxane 
functional group in the backbone of poly(dimethylsiloxane) (PDMS), for 
instance, made this biocompatible polymer as a first candidate for 
fabrication of a bioactive organic-inorganic hybrid [351-353]. Despite the 
promising bioactivity and mechanical performances of these interpenetrated 
networks [354, 355], their slow degradation profiles restrict their 
applications in tissue engineering. More recently, a porous and crack-free 
monolith was fabricated from PDMS-TEOS hybrids incorporated with PCL 
pellets for bone repair applications [356]. The mechanical properties and 
degradation profile of these monoliths, however, were not evaluated. 
Poly(ɛ-caprolactone) is a biocompatible and biodegradable aliphatic 
polyester with an extensive range of applications in the biomedical 
application [357-362]. The incorporation of metal oxide precursors 
including titanium oxide [363], zirconium oxide [364], and silica [365] 
within PCL solutions formed bioactive interpenetrated networks for tissue 
engineering [366] and drug delivery systems [367]. The hydrolysis of these 
metal oxide precursors yielded to the formation of hydroxyl groups. Further 
formation of hydrogen bonds between these hydroxyl groups with carbonyl 
functional groups of PCL enhanced the compressive modulus of hybrids up 
to 310 MPa [368] and improved their angiogenesis and osteogenesis 
properties [369]. These brittle monoliths, however, tolerated a very limited 
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range of compression, and they lost their physical integrities under 10.8 % 
compressive strain [370].  
Poly(vinyl alcohol) (PVA) is a water-soluble poly(hydroxylate) with 
thermoplastic features [371-373]. The presence of hydroxyl groups in the 
structure of this polymer facilitates the formation of interpenetrated network 
with inorganic compounds [374]. A solution of BG, for instance, was 
incorporated within a PVA solution to form a cytocompatible construct with 
a compressive modulus of 5.9 MPa [375]. This hybrid, however, 
demonstrated a fast dissolution profile, and brittle structure with an ultimate 
compressive strain of 5 %. These shortfalls were overcome by chemical 
crosslinking of the organic phase [376]. The presence of glutaraldehyde as a 
crosslinking agent enhanced their ultimate compressive strain 3-fold [377]. 
The degradation profile of these cytocompatible hybrids was also modified 
to surface erosion upon chemical crosslinking [378].  
Despite the significant enhancement of physicochemical and mechanical 
properties of the hybrids, these interpenetrated networks are formed through 
hydrogen bond formation between the residual hydroxyls of silica and 
polymer molecules. These interactions, however, are weak and unstable in 
aqueous media [29]. These drawbacks could be addressed by covalent bond 
formation between the polymer and the inorganic components. In the next 
session, the application of covalently bonded organic-inorganic hybrids in 
tissue engineering is reviewed. 
2.5.2 The Fabrication of Covalently Bonded Organic-Inorganic 
Hybrids 
The second type of hybrids is formed through the covalent bonding of a 
polymer into an inorganic compound. Prior to hybridisation, the preformed 
polymer is converted to its alkoxysilyl derivative (i.e., R`-C-Si-(OR)3) to 
form a covalent bridge with a metal oxide component. The fabricated alkyl 
carbon-silicon is an inert bond toward the hydrolysis and does not change 
the rate of alkoxides hydrolysis from the silicon centre. The pendant silyl 
group, therefore, is incorporated into the inorganic structure to form a 
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covalently bonded organic-inorganic hybrid. The alkoxysilylation of 
polymer carries out in two different approaches. In the first approach, the 
hydrosilation reaction takes place through the terminal alkene functional 
groups of the polymer in the presence of platinum as a catalyst [379, 380]. 
The presence of toxic organic solvents and the complicated nature of this 
approach restrict the application of these polycarbosilanes in tissue 
engineering.  
In the second approach for the fabrication of organic-inorganic hybrids, an 
organosilane coupling agent makes a covalent bridge between a polymer 
and an inorganic network [75, 381]. The organosilane coupling agent is a 
heterobifunctional compound that forms a covalent bond with a polymer 
through its functional organic terminal. The other silane terminal, however, 
goes through hydrolysis and condensation reactions with the inorganic 
phase [382]. The chemical interaction of cellulose acetate and 3-
(isocyanatopropyl)-trimethoxysilane as a coupling agent, for instance, forms 
cellulose urethane with pendant alkoxysilane groups. The hydrolysis and 
further condensation of these pendant groups with hydrolysed TEOS 
solution turn to a covalently bonded cellulose-silica hybrid with enhanced 
mechanical performances [383-385].  
Different natural and synthetic polymers were converted to their 
organosilane derivatives to form a covalently bonded hybrid for biomedical 
application [386]. A polyelectrolyte complex, for instance, was fabricated 
by the combination of organosilane derivative of alginate and tetramethyl 
orthosilicate (TMOS). A modified derivative of alginate by 3-
(aminopropyl)-trimethoxysilane (APTMS) formed a hydrogel in the 
presence of calcium chloride as a crosslinking agent. The resulting 
microbeads were then immersed into an n-hexane solution of TMOS to 
covalently coat with silica [386]. The encapsulation of pancreas islets of 
Langerhans into these microbeads followed by in vivo transplantation into 
mice confirmed their feasible application as an artificial pancreas [387]. The 
presence of metal oxide in organic-inorganic hybrid displays an intrinsic 
bioactivity that is preferable for bone tissue engineering applications. To 
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this end, different natural and synthetic polymers were covalently bonded to 
the silica precursors. The physicochemical properties and mechanical 
performance of these hybrids are presented in Table  2-1.  
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Table  2-1 The physicochemical and mechanical properties of covalently bonded 
hybrids for bone tissue engineering 
Organic 
Phase 
Hybrid 
Formation*;†;‡ 
Physicochemical and Mechanical 
Propertiesϸ 
Ref 
Chitosan I;-;A&B ESR= 0.50 mg/mg; E= 4.5 MPa; 
σ= 20 MPa; ɛ= 5% 
[388-391] 
Collagen I&II;-;C&D - [392, 393] 
Gelatin I;-;A&B&E 
I;1&2;A&B 
I;2;F 
I;3;B 
I;4;F 
ESR= 7.38 mg/mg; E=1.94MPa; ɛ= 17.34% 
- 
E= 331-1270 kPa; ɛ= 5.2-8.88 % 
σ= 4.3 MPa, ESR= 0.15 mg/mg 
[394-396] 
[397-399] 
[400, 401] 
[402] 
[403] 
PCL III;2;G - [404] 
PDMEMA IV;5;B&F H= 527 MPa [405-407] 
PGA I;6;F&H H= 520 MPa; E= 30-40 MPa; σ= 3-10 MPa; 
ɛ= 15-32% 
[408-411] 
PLLA II;3&7;B&F - [412, 413] 
PMMA IV;2;I H= 3.14 MPa; E= 6 MPa; ɛ= 14% [414] 
*Organosilane coupling agent: I: (3-Glycidoxypropyl) trimethoxysilane; II: (3-
Aminopropyl) triethoxysilane; III: (3-Isocyanatopropyl) triethoxysilane; IV: (3-
Methacryloxypropyl) trimethoxysilane. 
†Inorganic Precursor: 1. Calcium nitrate; 2. Tetraethyl orthosilicate; 3. Tetraethyl 
orthosilicate-Hydroxyapatite; 4. Tetramethyl orthosilicate; 5. Zirconium peroxide; 6. 
Tetraethyl orthosilicate-Calcium nitrate; 7. Calcium carbonate. 
‡Biological evaluations: A: MG63; B: MC3T3-E1; C. L-929; D: C2C12; E: Neonatal 
olfactory bulb ensheathing cell; F: Mesenchymal stem cell; G: in vitro Mesenchymal stem 
cell and in vivo study in Rabbit; H: Saos-2; I: in vitro primary osteoblast and in vivo study 
in Mice. 
ϸESR: Equilibrium swelling ratio; H: Hardness; E: Young modulus; σ: Ultimate stress; ε: 
Ultimate strain. 
Materials: PCL: Poly(ɛ-caprolactone); PDMEMA: Poly((dimethylamino) 
ethylmethacrylate); PGA: Poly(ɣ-glutamic acid); PLLA: Poly(L-lactic acid); PMMA: 
Poly(methyl methacrylate). 
Formation of Covalent Bonding between Natural Polymers and 
Inorganic Precursors 
The natural bone comprises from a homogeneous hybrid of collagen and 
hydroxyapatite [415, 416]. The formation of collagen-inorganic complex, 
therefore, is fascinating to mimic the bone structure [22, 417]. Despite the 
extensive applications of collagen-hydroxyapatite composites [418-421], the 
collagen-inorganic hybrids were limited to the organosilation of collagen in 
the absence of inorganic precursors [392, 393]. The hydrogel formation 
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from a chemical modified collagen with (3-aminopropyl) triethoxysilane 
(APTES), for instance, displayed a 60-fold enhancement in their rheological 
properties [392]. The organosilation with (3-glycidoxypropyl) 
trimethoxysilane (GPTMS), moreover, enhanced the adhesion and 
proliferation of osteoblast cells on the surface of alkoxysilyl derivatives of 
collagen [393]. Chitosan is another biopolymer that chemically modified by 
GPTMS to form a hybrid [391]. This organosilation process yielded to the 
fabrication of porous structures with enhanced cytocompatibility towards 
the osteoblast progenitor cells [388-390]. 
Gelatin is another natural polymer that was hybridised with organosilane 
components. A condensed structure of gelatin, for instance, was fabricated 
in the presence of GPTMS [422]. In this process, the epoxy functional group 
of GPTMS grafted to the amino acid groups of gelatin. The self-
condensation of activated silane groups, moreover, acted as a crosslinking 
agent to form a hydrogel. Despite the significant enhancement of the 
mechanical performances, GPTMS crosslinking remarkably decreased the 
physicochemical properties and biological behaviours of these hydrogels 
compared to the other crosslinking methods [394, 395]. The inorganic 
proportion of these hybrids, moreover, could not be varied independently of 
the organosilane coupling agent. This restriction was addressed by the 
incorporation of different inorganic compounds such as calcium nitrate 
[398, 399, 423], TEOS [397, 401, 402], and TMOS [403] into the 
alkoxysilyl derivatives of gelatin. A gelatin-silica hybrid with tailorable 
physicochemical properties and mechanical performances was fabricated by 
incorporation of TEOS solution into the pre-functionalised solution of 
gelatin [400, 401]. The molecular weight of gelatin and the degree of 
organosilation were paramount factors to mimic the physicochemical and 
mechanical properties of these cytocompatible hybrids for an extensive 
range of applications [400, 401]. 
Poly(γ-glutamic acid) (PGA) is a biocompatible, natural-based polymer with 
a controllable profile of degradation. The sequence of glutamic acid residues 
presents in the collagen fibrils of bone and plays a significant role in the 
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nucleation of hydroxyapatite [424]. A bioactive hybrid of PGA and TEOS 
with an enhanced degree of cell proliferation was fabricated in the presence 
of GPTMS as a coupling agent [408]. The incorporation of different calcium 
sources into the inorganic phase of these hybrids, moreover, had a 
significant effect on their mechanical performances and degradation profiles 
[409, 410]. The ultimate compressive strain of these hybrids, for instance, 
was tuned in the range of 15-32 % upon the addition of different 
concentrations of calcium chloride [409]. Despite the significant 
improvements in the mechanical performance of hybrids, the presence of 
organic solvents in the fabrication process and restricting the encapsulating 
of biological motifs are the main drawbacks of these hybrids. 
Formation of Covalent Bonding between Synthetic Polymers and 
Inorganic Precursors 
The fabrication of organic-inorganic hybrids from synthetic polymers has a 
vast application in tissue engineering. PCL, for instance, was chemically 
modified in the presence of (3-isocyanatopropyl) triethoxysilane to form a 
covalent bond with silica [425-430]. The incorporation of MSC cells within 
these hybrids displayed a significant enhancement on their in vivo 
osteoconductivity in rabbit [404]. The organic-inorganic hybrids were also 
fabricated from the APTES-functionalised poly(L-lactic acid) in the 
presence of different bioactive glass solutions [412, 413]. The improved 
bioactivity of these hybrids in addition to the enhancement of cell 
proliferation introduced them as suitable candidates for bone tissue 
engineering.  
Poly(alkyl methacrylate)s such as poly(methyl methacrylate) (PMMA) and 
poly((dimethylamino) ethylmethacrylate) (PDMAEMA) are the other 
examples of synthetic polymers used for fabrication of organic-inorganic 
hybrids. The presence of methacrylate functional group in the backbone of 
these polymers facilitates the organosilation reaction in the presence of 
methacryloxy-possessed coupling agents. For instance, (3-
methacryloxypropyl) trimethoxysilane as an organosilane coupling agent 
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functionalised PMMA [431] and PDMAEMA [407] polymers prior to 
hybridisation. The addition of silica [414] or zirconia [405-407] into 
respectively PMMA and PDMAEMA solutions yielded to bioactive hybrids 
with enhanced mechanical performance and cell proliferation. The polymer-
hybridisation has extensive applications in bone tissue engineering. 
Regardless their natures (i.e. type I or II), these organic-inorganic hybrids 
are fabricated through sol-gel method. The chemistry of this approach is 
described in the next session.  
2.5.3 The Mechanism of Sol-Gel Process 
A homogeneous organic-inorganic hybrid is fabricated through the mild 
conditions of the sol-gel method. This approach is based on the hydrolysis 
and condensation reactions of an organosilane precursor in an aqueous 
solution of polymer [19]. The presence of polymer solution does not 
interfere with hydrolysis and condensation of an inorganic compound. In 
this session, therefore, the mechanism of a sol-gel method for a pure 
inorganic compound is reviewed in detail.  
In the first stage of the sol-gel process, the tetraalkyl orthosilicate as a 
precursor of BG goes through a hydrolysis reaction. The fabricated sol is a 
colloidal suspension of nanoparticles (size 1-100 nm) in an aqueous media 
supplemented with an acidic or basic catalyst. The condensation of these 
particles forms an interconnected network of submicron pores. This rigid 
network is converted into the gel structure in the second stage of the sol-gel 
process [432]. The physicochemical properties of the resulting hybrids 
depend upon the chemical composition of the catalyst, reactivity of 
inorganic compounds and the rates of hydrolysis and condensation 
reactions. The basic catalysed hybridisation, for instance, leads to the 
formation of multi-branched clusters [433]. The highly ramified structure is 
formed in the presence of acidic catalysts [434]. At low pH, moreover, the 
rate of hydrolysis is fast relative to condensation while using the basic 
catalyst reverses these relative rates and results in the formation of colloidal 
particles. The difference in cluster formation is also due to the higher 
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solubility of silicon oxide in alkaline media that enhances their inter-linking 
compared to acidic media [317]. 
Regardless of the chemical composition of the catalyst, the sol-gel process 
is a nucleophilic substitution reaction and comprises from hydrolysis and 
condensation reactions. The partial hydrolysis of tetraalkyl orthosilicate in 
the presence of various catalysts, as shown in Scheme  2-2, forms different 
silanol functional groups. 
 
Scheme  2-2 The schematic of acid- (A) and base-catalysed (B) hydrolysis reactions of 
silicate-based BG in the sol-gel process [19]. 
The condensation of these partially hydrolysed intermediates, as shown in 
Scheme  2-3, forms bridging oxygen and liberates water, ethanol, or 
methanol. These hydrolysis and condensation reactions are initiated at 
different sites of the solution with complicated kinetics. When a sufficient 
number of interconnected siloxane is formed in a particular region; their 
cooperative interactions turn to colloidal particles and form a 3D network of 
gel over time.  
A
B
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Scheme  2-3 The schematic of acid- (A) and base-catalysed (B) condensation reactions 
of silicate-based BG in the sol-gel process [19]. 
Following the gel formation, the condensed network goes through an ageing 
process to increasing the degree of condensation. The resulting materials 
then expulse the liquid phase, in the process called syneresis [435]. This 
drying process effectively prevents the formation of a 3D to the tendency of 
the hybrid network to shrink, crack and shatter [436, 437]. The large 
capillary forces generated within the pores of hybrid contribute to the drying 
stresses and yield to the shrinking and cracking of hybrid networks. The 
shattering, on the other hand, attributes to the solvent evaporation via either 
opening the reaction vessel at the ambient temperature or by placing the 
sample under mild vacuum [317]. These unfavourable side effects, however, 
can be minimised in different ways such as the controlled drying of a hybrid 
over the period of weeks or months. The addition of the pre-fabricated silica 
seeds during the sol-gel process, lyophilisation of the hybrid, the use of 
surfactant, control of drying step, and the presence of chemical additives are 
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the other approaches that can be used to increase the average pore size of 
condensed network and prevent the formation of cracks [438, 439]. Despite 
the formation of crack-free monoliths, the structure of the hybrid is still 
extensively shrunk (50-70 % of volume fraction) due to the presence of 
abovementioned capillary forces [317]. Therefore, it is critical to developing 
a new approach to addressing this issue and fabricating an organic-inorganic 
hybrid with enhanced physicochemical properties and mechanical 
performance. 
2.6 Summary 
This chapter described the demand for a new therapeutic approach to 
regenerating the bone. The current bone treatment techniques are entangled 
with several complications such as a donor site morbidity, disease 
infections, and deficient supply. Tissue engineering as a new approach was 
considered to overcome these burdens and regenerate bone structure. 
Among different approaches for bone regeneration, nanocomposite 
hydrogels have high potential to mimic the chemical composition of bone. 
The heterogeneous distribution of inorganic compound may have an adverse 
impact on biological behaviours of these hydrogels. This shortfall might be 
overcome by fabrication of organic-inorganic hybrid hydrogels. This 
approach, however, has not been exploited for bone tissue engineering. 
Different organic-inorganic hybrids with enhanced mechanical properties 
and bioactivity have been developed to mimic the bone structure. These 
biomaterials were fabricated through sol-gel method to distribute the 
bioactive glass homogeneously within the polymer phase. Different aqueous 
solutions of natural or synthetic polymers have been incorporated into 
hydrolysed solutions of bioactive glass to form a synergistic hybrid upon the 
condensation of bioactive glass. In particular, a collagen-inorganic hybrid 
could be the most favourable biomaterials for musculoskeletal tissue 
engineering, as these components comprise the chemical structure of bone. 
However, the limited mechanical properties of these hybrids may evoke 
severe clinical complications. Despite the nature of organic and inorganic 
components, the complete condensation of the inorganic phase carries out 
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through drying and aging steps and yields to the formation of brittle 
structures. The fabrication of two-dimensional monolith with very limited 
water uptake capacity is their main drawbacks for bone tissue engineering. 
2.7 Aim and Objectives 
The aim of this study was to develop a unique structure for reconstruction of 
bone and its interface with soft tissues. It was hypothesised that the 
fabrication of an organic-inorganic hybrid with elastic mechanical 
performance and high swelling ratio might enhance the proliferation of bone 
progenitor cells. To achieve this objective, a covalently bonded hybrid of 
gelatin-bioactive glass was fabricated through the sol-gel method. It was 
hypothesised that polymer-crosslinking could control the condensation of 
the inorganic phase and prevent the formation of brittle structure. In 
addition, it was anticipated that the addition of the secondary crosslinking 
agent might improve the mechanical performance of hydrogels without 
interfering with hybridisation. The effect of variables such as chemical 
structure and composition of hybrids on their physicochemical properties, 
mechanical performance, degradation profile and biological performance 
were examined. 
To achieve abovementioned objectives, it was planned to: (1) control the 
over condensation of inorganic phases in polymer-bioactive glass hybrids, 
(2) investigate the effect of covalent bond formation between gelatin and 
bioactive glass through organosilane coupling agents, (3) evaluate the 
impact of secondary polymer crosslinking on the physicochemical and 
mechanical properties of hybrid hydrogels, (4) study the impact of 
incubation media on the degradation profile and the mechanical 
performance of hybrid hydrogels, (5) conduct in vitro bioactivity and 
biological activity of these hybrid hydrogels, and (6) conduct animal study 
to assess their cytocompatibility, biological and biodegradable properties for 
bone repair. 
  
Chapter 3. Materials and 
Methods
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3.1 Introduction 
The intrinsic brittleness of pure bioactive glasses (BG) significantly restricts 
their biomedical applications [5, 297, 303]. Recent studies show that 
chemical bonding of BG with a polymer and fabrication of organic-
inorganic hybrids addresses this shortcoming of bioactive glasses and 
promotes their physicochemical and mechanical properties [428, 440]. 
While these hybrids were less brittle, over-condensation of silica networks 
may still lead to acquiring the brittle monolithic structure. The aim of this 
study was to reduce the risk of over-condensation and fabricate a 3D 
structure of polymer-BG hybrid with enhanced physicochemical and 
mechanical properties. It was hypothesised that the polymer crosslinking 
can interfere with silica network formation and could be used as a method to 
control the condensation of the inorganic phase. To assess this hypothesis, 
gelatin was selected as a polymer phase due to its capacity to form hydrogel 
through different approach: physical [441], chemical [156, 173, 223] and 
photocrosslinking [235]. In this chapter, various methods for the fabrication 
of different types of the gelatin-BG hybrid hydrogel are described. In 
addition, the characterisation techniques that were used to assess mechanical 
performance, physicochemical and biological properties of these hybrids are 
described in detail. 
3.2 Materials 
Gelatin type A, soluble starch, poly(ethylene glycol) diacrylate (PEGDA, 
Mn 700), methacrylate anhydride (MA, 99%), (3-aminopropyl)-
triethoxysilane (APTES), (3-glycidoxypropyl)-trimethoxysilane (GPTMS), 
tetraethyl orthosilicate (TEOS), tetramethyl orthosilicate (TMOS), and all 
other chemicals and solvents were in reagent grade and purchased from 
Sigma-Aldrich (USA) unless specifically mentioned. 2-hydroxy-1-(4-
(hydroxyethoxy)phenyl)-2-methyl-1-propanone (Irgacure 2959®) as a 
photoinitiator was supplied by Ciba Geigy. Genipin was purchased from 
Wako Chemicals (Japan). Phosphate buffer saline (PBS, pH 7.4 and 0.1 M) 
was prepared by dissolving PBS tablets (Medicago, Sweden) in 100 ml of 
deionised water (Millipore, USA). Simulated body fluid (SBF, pH 7.42) was 
Page | 39 
 
prepared based on the method described by Kokubo et al. [442]. Briefly, 
proper amounts of sodium chloride and sodium sulphate (Merck 
Chemicals), potassium chloride and calcium chloride (Silform Chemicals), 
sodium bicarbonate, potassium phosphate dibasic and magnesium chloride 
(Sigma-Aldrich) were dissolved in deionised water at 36°C and the pH was 
adjusted between 7.42 and 7.45 by addition of Tris (Plus one) and 1 M 
solution of hydrochloric acid (HCl 32 %, Merck Chemical). All these 
chemicals and reagents were used without further purification. 
McCoy’s 5A medium modified, propidium iodide and paraformaldehyde 
were purchased from Sigma-Aldrich. Alkaline phosphate assay kit was 
purchased from Abnova®. Fetal bovine serum, L-Glutamine, Antibiotic-
Antimycotic, trypsin-EDTA, and 4', 6-diamidino-2-phenylindole (DAPI) 
and all other reagents for in vitro biocompatibility assays were supplied by 
Life Technologies unless specified. 
3.3 Synthesis of Photocrosslinkable Gelatin 
Photocrosslinkable gelatin was synthesised by converting the gelatin to its 
methacrylated derivative (GelMA) by using the method described by Van et 
al. [443]. Briefly, MA (13.4 mmol, 20 ml) was added drop wise 
(0.4 ml/min) to a 100 mg/ml solution of gelatin in PBS at 50°C to control 
the pH of the final product. The precise amounts of gelatin and MA were 
presented in Appendix A, Table 1. After one hour, the reaction ceased by the 
addition of 500 ml pre-heated PBS media. The GelMA solution was then 
dialysed against distilled water using 12-14 kDa cutoff dialysis tubes at 
37°C until the pH was increased to 6. The purified GelMA solution was 
then lyophilised at -80°C and the resulting foams were kept in the dry and 
cool environment to avoid moisture absorption.  
The degree of methacrylation in GelMA was quantified using proton 
nuclear magnetic resonance (1HNMR) analysis (Varian INOVA NMR, 
USA). The 1HNMR spectra were collected at 35°C in deuterium oxide at a 
frequency of 500 MHz. Phase and baseline correction were applied before 
obtaining the integral of peaks, and the analysis was repeated at least triple. 
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It was found that GelMA with 80% degree of methacrylate was synthesised 
[254]. 
3.4 Synthesis of Photocrosslinkable Starch 
Starch was converted to its methacrylated derivative (StaMA) using the 
method described by Caldwell et al. [444]. Briefly, the slurry of 400 mg/ml 
of starch in PBS was prepared at room temperature. The pH of the slurry 
was increased to 8-9 by the addition of 3 wt% solution of sodium hydroxide 
(NaOH, Merck Chemicals). Methacrylic anhydride in 4.5:1 molar ratio of 
starch: MA was added to the slurry drop wise (0.3 ml/min), and pH was 
adjusted to 8-9 using NaOH solution. The precise amounts of starch and 
MA were presented in Appendix A, Table 2. Following 1 h agitation at room 
temperature, pH was decreased to 6.5-7. The StaMA was then dialysed 
against deionised water for 3 days and then separated by centrifugation at 
3500 rpm for 30 min. The sediments were then lyophilised at -80°C and the 
resulting powders were kept in a desiccator. 
3.5 Preparation of Bioactive Glass Solution  
Bioactive glass (BG) was prepared using the sol-gel method, in which 
TEOS was dissolved in 40 mM hydrochloric acid (HCl) in 8:1 molar ratio 
of TEOS: HCl solution. The precise amounts of these precursors were 
presented in Appendix A, Table 3. The mixture was stirred for one hour at 
room temperature to prepare a homogeneous solution. This solution was 
then used for the formation of either the interpenetrated gelatin-BG 
hydrogel or hybrid hydrogels. 
3.6 Fabrication of Interpenetrated Gelatin-BG Hybrid 
Hydrogels 
The interpenetrated network of gelatin-BG hydrogel was fabricated by the 
sol-gel method followed by different methods of polymer crosslinking. For 
the fabrication of all hydrogels, 100 mg/ml solution of gelatin was prepared 
in PBS at 50°C. Prior to the fabrication of interpenetrated gelatin-BG 
network, the temperature of the reaction was set at 37°C. Different 
concentrations of BG (0-6 µl BG per milligram of the organic phase) were 
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incorporated into the solutions immediately followed by addition of 
crosslinking agents. Genipin in the different final concentrations (1-
7.5 mg/ml) and Irgacure (1 mg/ml) were added to the gelatin-BG solutions 
to form respectively chemically- and photocrosslinked hydrogels. The 
precise amounts of gelatin, crosslinking agents and BG were presented in 
Appendix A, Table 4. The BG-gelatin solutions were then poured into 
custom-made moulds to form different incorporated BG-gelatin hydrogels. 
While the physically crosslinking process was accomplished at room 
temperature in the absence of crosslinking agents, the genipin-contained 
solutions were kept at different temperatures (37°C -60°C) to complete the 
chemical crosslinking reaction. The photocrosslinking, on the other hand, 
was accomplished by irradiation of the GelMA-BG solution supplemented 
by Irgacure under ultraviolet light (UV, 365 nm, 6.9 mW/cm2). 
3.7 Fabrication of Covalently-Bonded Gelatin-BG Hybrid 
Hydrogels using Organosilation Technique 
Prior to the hybrid formation, GelMA was functionalised with different 
organosilane coupling-agents to prepare a silane group in GelMA (Fn-
GelMA) for covalent bonding with BG. Therefore, GPTMS or APTES was 
added to different concentrations of GelMA (75, 100 and 150 mg/ml) in 
PBS and stirred for at least 12 h at 40°C. The molar ratio of 2:1 between 
hydroxylysine, lysine and arginine amino groups of GelMA and 
organosilane coupling agents was obtained through addition of 92 µl of 
these agents per each gram of GelMA. The constant concentration of 
Irgacure (1 mg/ml) as a photo-initiator was then added to the GelMA-based 
solutions. Subsequently, different amounts of BG with respect to organic 
phase, i.e. GelMA, (0-1 µl per each milligram of GelMA) were added to the 
photocrosslinkable solution to form a hybrid solution. The precise amounts 
of GelMA, organosilane agents and BG were presented in Appendix A, 
Table 5. 
The degree of crosslinking was also increased upon conjugation of different 
photocrosslinkable polymers. To this end, various concentrations of StaMA 
(0-20 mg/ml) or PEGDA (0-100 mg/ml)) were added to the GelMA solution 
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(100 mg/ml). The effect of secondary crosslinking on the covalently bonded 
hybrids was also investigated by the addition of these polymers to Fn-
GelMA. Different amounts of BG (0-1 µl) were incorporated into 
conjugated solution with respect to the amount of organic content (i.e. the 
mass of GelMA and secondary crosslinking agent). The chemical 
composition of various hydrogels is determined in Table  3-1 and Appendix 
A (Tables 6 and 7). Despite their chemical compositions, the prepared 
photocrosslinkable solution was poured into a custom-made mould (Plastic 
Petri Dish with an internal diameter of Φ=35 mm) to fill the mould up to 
2 mm. The solution was then photocrosslinked under UV light (365 nm, 
6.9 mW/cm2) to form a hydrogel. The required time for hydrogel formation 
was measured while a solid 3D structure was fabricated. 
Table  3-1 The chemical composition of various covalently bonded hydrogels 
fabricated by 1 mg/ml Irgacure  
Hydrogel GelMA 
(mg/ml) 
Secondary 
Crosslinking Network 
BG: 
Polymer 
(µl/mg) StaMA 
(mg/ml) 
PEGDA 
(mg/ml) 
Fn-GelMA 75-150 - - - 
Fn-GelMA-BG 75-100 - - 0-1 
Fn-GelMA-StaMA-BG 100 0-20 - 0-1 
Fn-GelMA-PEGDA-BG 100 - 0-100 0-1 
 
3.8 Attenuated Total Reflection Fourier Transform Infrared 
Spectroscopy 
Attenuated total reflection Fourier transform infrared (ATR-FTIR, Varian 
660 IR, 4000–650 cm-1) at a 4 cm-1 resolution and 32 scans in absorbance 
mode was conducted to evaluate the chemical structures of dried hydrogels 
and also methacrylated starch. 
3.9 Thermal Gravimetric Analysis 
The effect of methacrylation on the thermal properties of starch was 
investigated by thermal gravimetric analysis (TGA, Q500) with the 
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assistance of Mr. Ehsan Pourazadi, School of Chemical Engineering. The 
thermal stability of starch was monitored while the temperature was 
increased from ambient temperature to 500°C with a ramping rate of 
2.5°C/min under N2 stream of 60 ml/min. 
3.10 Quantification of amine functional groups 
The mechanism of organosilation was determined using colorimetric 
quantification of amine functional groups on GelMA structure. In this well-
established method, the amine functional group in a biopolymer is measured 
quantitatively using UV spectroscopy via observing the conversion of the 
yellowish colour of ninhydrin solution to the dark purple. In each run, 1 ml 
of 2 wt% ninhydrin in ethanol solution was added to 1 ml of 1.5 wt% 
solutions of plain and Fn-GelMA at 37°C. The temperature was then 
gradually increased to 80°C under mild stirring. The solution was kept at 
this temperature for 15 min to complete the reaction and then cooled down 
to ambient temperature. The degree of amine functional group (Da) was 
calculated by Equation 1 based on the recorded light absorbance at 410 nm 
(Bio-Rad 680 microplate reader).  
𝐷𝑎 = [(𝐵 − 𝐴)/𝐴] × 100     Equation 1 
where A is the mole fraction of free amine functional groups in GelMA and 
B represents the mole fraction of Fn-GelMA. The Da of functionalized 
GelMA by APTES in the abovementioned conditions (16 %) was used as a 
control to determine the mechanism of GPTMS functionalisation. The 
amine functional groups of APTES formed a covalent bond with carboxylic 
acid groups of GelMA. 
The presence of amine functional groups in Fn-GelMA hydrogel was also 
determined qualitatively using fluorescein isothiocyanate (FITC, Sigma-
Aldrich) assay. In this method, the sample was incubated in 1 mg/ml 
solution of FITC in PBS in the dark container. After 24 h incubation at 
ambient temperature, the hydrogel was washed against deionised water, and 
the absorbance of FITC was collected at 495 nm. A cylindrical sample was 
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fabricated from poly(L-lactic acid) (PLLA) to use as a positive control. This 
sample was incubated in the abovementioned conditions in FITC solution. 
3.11 Swelling Properties 
The swelling behaviour of hydrogel was measured at 37°C in PBS. The dry 
weight of hydrogels (Wd) was recorded after lyophilizing overnight. 
Subsequently, the hydrogels were immersed in excessive PBS overnight 
followed by weighting (Ws). The equilibrium swelling ratio (ESR) was then 
calculated using Equation 2. 
𝑬𝑬𝑬 �𝒎𝒎
𝒎𝒎
� =  𝑾𝒔−𝑾𝒅
𝑾𝒅
      Equation 2 
3.12 Mechanical Properties 
The mechanical performance of hydrogels was investigated using uniaxial 
compression tests (Instron 5943, 100 N load cell). The hydrogels were 
punched using 8 mm biopsy to form disks (Φ= 8 mm, h=2 mm) and swelled 
for 2 h in PBS at 37°C unless specifically mentioned. The hydrogels 
underwent 3 cycles of compression-decompression with a compression rate 
of 0.05 mm/min in the hydrated state at 37°C. The compressive modulus 
was then obtained from the tangent slope of the stress–strain curve in the 
linear strain range (10-20%). In addition, for all samples, the energy loss 
based on the compression cycle was computed. 
3.13 Degradation Profile of Hydrogels 
The degradation profiles of samples were measured based on the released 
protein and silicate anions in different media (i.e. PBS and SBF). The 
lyophilized samples were weighed prior to the test and incubated in different 
media at 37°C for a period of time. The protein concentration of each 
sample was measured using Qubit® Protein Assay Kits (Invitrogen) with 
considering the media absorbance as a background. The protein calibration 
curves were linear for known concentrations of GelMA in different media 
(PBS: R2=0.99; SBF: R2=0.98). The degree of protein release was 
calculated based on the concentration of protein with respect to the dried 
weight of samples. 
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The profile of silica degradation was also monitored using 
spectrophotometric analysis as described by Coradin et al. [445]. In each 
particular time interval, 1 ml of media was diluted with 15 ml deionised 
water. The diluted media were then mixed with 1.5 ml of 102 mM 
ammonium molybdate solution in 2.45 mM HCl. After 10 min vigorous 
shaking of this solution at room temperature, the released silica ions were 
conjugated with molybdate anions and formed a yellowish solution. This 
solution, however, could be formed due to the formation of 
phosphomolybdate or the possible reaction between GelMA and molybdate 
ions. These unfavourable salts, therefore, were eliminated from the solution 
by addition of 7.5 ml of secondary solution contained 22 mM oxalic acid, 
32 mM sodium sulphite and 39 mM metol in 1.9 mM sulphuric acid [445]. 
The colour of the solution was changed to blue upon addition of the 
secondary solution. After 2 h agitations at ambient temperature, the amount 
of released silica was measured at 810 nm using UV-Vis spectroscopy 
(Cary 60, Agilent Technologies). In this study, the calibration line was 
prepared for known concentrations of TEOS (R2=0.99) prior to analysis and 
SBF solution was used as the background. The degree of Si release was 
calculated based on the concentration of Si with respect to the dried weight 
of samples. 
3.14 Bioactivity of Hydrogels 
Scanning electron microscopy with energy dispersive X-ray spectroscopy 
(SEM-EDS, Zeiss EVO) at 15 KV was used to determine the bioactivity of 
hydrogels following SBF incubation at 37°C. Hydrogels were removed from 
SBF at a specific time, washed with deionised water, lyophilized, mounted 
on aluminium stubs and then carbon sputtered prior to SEM-EDS analysis. 
The AZtec software (Oxford Instruments, UK) was integrated to SEM to 
identify the chemical composition of hydrogels before and after SBF 
immersion. At least three different images with similar magnifications were 
collected to measure the amount of precipitated ions on their surfaces.  
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3.15 In Vitro Cell Culturing  
Saos-2 osteoblast cells were cultured in McCoy’s 5A medium supplemented 
with 10% fetal bovine serum, 1% L-Glutamine and 1% Antibiotic-
Antimycotic in 75 cm2 tissue culture flasks (BD Biosciences, USA). Cells 
were passaged weekly, and media was changed every two days. Cells were 
incubated at 37°C with 0.5% CO2 (Incubator Thermo Fisher Heracell 150i). 
3.15.1 Cell Seeding of Hydrogels 
The hydrogels were fabricated in aseptic condition with pre-sterilised 
components to eliminate the sterilization with ethanol. The presence of 
ethanol within hydrogels may have adverse effects on their degradation 
profile and also cell viability. Prior to cell seeding, the hydrogels were cut 
into small disks (Φ= 8 mm, h=2 mm) and transferred to 48-well plates. The 
prepared hydrogels were then rinsed with sterilized PBS followed by 
incubation in prepared media overnight. Saos-2 cells were trypsinised, 
counted and resuspended in fresh media at a density of 200,000 cells/ ml. 
The pre-determined amounts of cells were then seeded onto the surface of 
hydrogels and were placed in a CO2 incubator at 37°C. 
3.15.2 Live-Dead Assay and Bone Specific Analyses  
The cell viability and proliferation were measured by double staining of the 
cells cultured on the surface of hydrogels. After 14, 21 and 28 days of 
incubation, hydrogels were transferred to the new well-plate contained 1 ml 
of fresh media. The nuclear of dead cells was stained by addition of 1 µl 
propidium iodide solution (PI, 1 mg/ml) followed by 30 min incubation at 
37°C. The PI-stained hydrogels were thoroughly rinsed with PBS and then 
fixed by 10 min soaking in 4% paraformaldehyde (PFA) at 37°C. The 
residue of PFA was then removed by several rinsing steps of hydrogels with 
PBS. The DNA-specific 4', 6-diamidino-2-phenylindole (DAPI) was used to 
stain the nuclear of cells. The samples were then placed on a glass slide for 
confocal laser scanning microscopy (LeicaSP5, Germany) examination. The 
confluence of cells on the hydrogel was determined by analysing fluorescent 
images using the Fiji-ImageJ software. 
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The differentiation of Saos-2 osteoblast cells was determined using alkaline 
phosphate assay (ALP). After 14, 21 and 28 days cell culturing, the cells 
were trypsinised from the surface of hydrogels, and their ALP activities 
were evaluated based on manufacture’s procedure. 
3.16 In Vivo Animal Study 
The in vivo cytocompatible, degradation and the biological properties of the 
hybrid hydrogels were studied by using mice subcutaneous implantation 
model. These hydrogels were pre-fabricated in vitro as described in  3.15.1. 
The surgeries were carried out in ANZAC Research Institute in Concord 
Hospital with the direct assistance of Dr. Yiwei Wong.  
Nine pathogen-free, male BALB/c mice, aged 6 months with 28±1.7 g were 
acquired, housed and studied under a protocol approved by SLHD Animal 
Welfare Committee in Sydney, Australia (#2013/019A). Each mouse was 
anesthetised individually by intraperitoneal injection of a mixture of 
ketamine (75 mg/ml) and xylazine (10 mg/ml) at 0.01 ml/g of body weight. 
The dorsal hair was shaved and skin was cleaned with Betadine solution and 
washed with sterile saline. The incision was created surgically in the dorsal 
area and dissected to create a subcutaneous pouch into which the hydrogel 
was inserted. The wounds were then closed with 5-0 silk sutures and 
covered by Atrauman® (Hartmann, Australia) and IV3000 wound dressings 
(Smith & Nephew) for 7 days. Carprofen (5 mg/kg) was given at the time of 
anaesthesia and then on the following day post-surgery for analgesia. After 
surgery, each mouse was caged individually for the first two days and then 
three mice per cage thereafter with free access to water and food. Skin 
biopsies were collected for histological analysis at 1, 2 and 4 weeks post-
implantation. 
3.16.1 Haematoxylin and Eosin Staining 
Skin biopsies with implanted conjugated hybrid hydrogels were fixed in 
100 mg/ml formalin for 24 h. All samples were then dehydrated and 
embedded in paraffin. The 5 µm sections were deparaffinised in xylene and 
stained with Haematoxylin and Eosin (H&E). 
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3.17 Statistical Analysis 
All experiments were repeated at least for three times. Data was reported as 
mean±STD. A one-way analysis of variance (ANOVA) for single 
comparisons and Bonferroni Post-Hoc tests for multiple comparisons were 
performed, using IBM SPSS software for Windows, version 21. Statistical 
significance is accepted at p<0.05 and indicated in the Figures as * (p<0.05), 
** (p<0.01) and *** (p<0.001), no star represents no statistical significance. 
  
Chapter 4. Fabrication of an 
Interpenetrated Network of 
Organic-Inorganic Hybrid 
Hydrogel 
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4.1 Introduction 
The polymer-bioactive glasses formed through sol-gel method are 
commonly brittle monoliths with low water uptake capacity due to the over-
condensation of their inorganic phases [414]. The aim of this study was to 
fabricate 3D networks of polymer-BG with enhanced swelling properties 
and mechanical performance. In this part of the study, it was hypothesised 
that the combination of sol-gel method and polymer crosslinking can control 
the condensation of the inorganic phase and thus prevents the formation of 
brittle structure. In this study, gelatin was used as a polymer model due to 
its intrinsic capacity to form a hydrogel through different methods of 
crosslinking [446-448]. The gelatin solution in constant concentration 
(100 mg/ml) was prepared at 37°C and turned to the hydrogel using 
different methods. The physically crosslinked hydrogel was formed by 
cooling the solution at room temperature. The genipin, however, was used 
to crosslink the gelatin chains chemically. Finally, a photoinitiator was used 
to rapidly crosslink a gelatin that was methacrylated. In this chapter, the 
effects of different processing parameters, such as temperature and the 
concentration of crosslinking agents on the interpenetrated gelatin-BG 
network structure were examined. 
4.2 The Effects of External Stimuli on the Gelatin Hydrogel 
Formation and the Gelation of BG 
Prior to the fabrication of gelatin-BG hybrids, the rates of both BG 
condensation and the gelatin crosslinking were measured. It was ideal to 
select the conditions that both these compounds simultaneously are forming 
the gel to prepare a homogeneous macrostructure. To this end, two critical 
factors, the reaction temperature, and the concentration of crosslinking 
reagents were optimised [449-451]. 
The temperature was varied between 25°C and 60°C. The pure BG turned to 
a brittle structure after 3 h incubation at room temperature. Increasing the 
temperature to 37°C and 60°C, however, resulted in the formation of 
condensed networks of BG within 10 min and 2 min, respectively. This 
remarkable increase in the rate of BG condensation was due to the higher 
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rates of aggregation and collisions of activated silanol groups at elevated 
temperatures [452].  
Genipin crosslinking resulted in a change of colour of solution from clear to 
dark blue and also converting liquid to highly viscous gel. These are simple 
tests for determining the degree of crosslinking while the darker blue colour 
is an indication of stronger crosslinking reaction. In fact, other methods such 
as FTIR were not that sensitive due to the fact that the carboxylate 
functional groups and also amino acid were still present in the final 
crosslinked hydrogels. 
The temperature had a significant impact on the hydrogel formation as the 
gelatin solution formed a physically crosslinked hydrogel below 35°C [453, 
454]. While the physically crosslinked hydrogel was formed after 10 min 
incubation of gelatin solution at room temperature, at least 30 min was 
required to form a hydrogel when using different concentrations of genipin 
as a chemical crosslinking agent at 37°C. Data in Figure  4-1A show that the 
concentration of genipin and the temperature had significant effects on the 
gelation time of hydrogels. Despite the temperature of the reaction, 
increasing the concentration of genipin had a significant impact on the 
hydrogel formation. For instance as shown in Figure  4-1A, when the 
concentration of genipin was increased from 1 mg/ml to 2.5 mg/ml, the 
gelation time at 37°C was decreased 6-fold from 180 min to 30 min 
(p<0.001).  
Increasing the concentration of genipin at a constant temperature or 
elevating the temperature of the reaction for similar concentrations of 
genipin significantly decreased the gelation time of hydrogels. The 
statistical analyses through Bonferroni Post-Hoc tests, however, revealed 
that the effect of temperature on the gelation time of hydrogels (p<0.05) was 
marginally significant compared to the genipin concentration (p>0.05). 
Increasing the concentration of genipin from 2.5 mg/ml to 5 mg/ml at 37°C, 
for instance, did not have a significant effect on the gelation time of 
hydrogels. Incubation of these hydrogels at 60°C, however, significantly 
decreased their gelation times from 60 min to 30 min (Figure  4-1A, p<0.05). 
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The physicochemical properties of hydrogels were also dependent upon 
these two key factors (i.e. reaction temperature and the concentration of 
crosslinking agent). Increasing the concentration of genipin at a constant 
temperature significantly decreased the physicochemical properties of 
hydrogels. The swelling ratio of hydrogels, however, did not significantly 
alter by increasing the reaction temperature for a constant concentration of 
genipin (Figure  4-1B). For instance, the swelling ratio of hydrogels 
fabricated at 37°C was remarkably decreased from 6.7±0.3 mg/mg to 
5.8±0.1 mg/mg upon increasing the concentration of genipin from 
2.5 mg/ml to 5 mg/ml (p<0.05). Elevating the incubation temperature to 
60°C, however, did not have a significant effect on their swelling ratios 
(p>0.05). Data in Figure  4-1 reveal that the optimum hydrogel with proper 
swelling ratio and fast gelation time was formed upon the incubation of 
gelatin solution supplemented with 2.5 mg/ml genipin at 60°C. 
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Figure  4-1 The effects of genipin concentration and crosslinking temperature on the 
hydrogel formation (A) and swelling ratio (B) of gelatin hydrogels. Data presented in 
*, ** and *** represent p<0.05, p<0.01 and p<0.001, respectively. 
The photocrosslinking of methacrylated gelatin (GelMA) in the presence of 
Irgacure as a photoinitiator was a fast method to form a hydrogel within 
2 min. The temperature has a negligible effect on the gelation time of 
photocrosslinked hydrogels. In addition, when using more than 0.25 mg/ml 
the residue of Irgacure evokes significant drawbacks on biocompatibility 
and physicochemical properties of hydrogels [455-457]. Therefore, it was 
attempted to use the minimal amount of Irgacure required for 
photocrosslinking.  
*** ***
(A)
***
***
*
**
*
(B)
***
***
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The different methods of crosslinking provided the particular conditions to 
investigate the effect of polymer crosslinking on the controlling of BG 
condensation and thus the formation of an interpenetrated network of BG 
and gelatin.  
4.3 Fabrication of Interpenetrated Gelatin-BG Hybrid Hydrogel 
through Physical or Chemical Crosslinking of Polymer 
The effects of polymer crosslinking on the formation of interpenetrated 
network of gelatin-BG were studied. The physical and chemical methods of 
crosslinking were used to form hydrogels before or after the condensation of 
BG. Despite the method of crosslinking, different concentrations of BG (0-
6 µl/mg) were incorporated into the gelatin solution at 37°C. It was found 
that the brittle structure was immediately formed upon the addition of high 
concentration of BG (more than 2 µl/mg) in the gelatin solutions prior to 
crosslinking. In these arbitrary structures, gelatin was entrapped within the 
condensed network of BG, and this network did not lose its integrity upon 
increasing temperature to 60°C. It seems that this entrapment was due to the 
differences in the isoelectric points (IEP) of gelatin and BG.  
Gelatin with IEP of 8.6 possesses the positive charges in the PBS media (pH 
7.4), while BG with IEP of 2.6 represents the negative charges in the 
environment with pH higher than its IEP [458, 459]. The interactions 
between gelatin and BG, therefore, enhanced the condensation of silicate 
anions and formed the brittle structures. This result was in agreement with 
the previous study by Heinemann et al. while their collagen solutions 
simultaneously solidified upon the incorporation of higher concentration of 
pre-hydrolysed tetramethyl orthosilicate due to increasing the rate of 
aggregation [348]. The degree of silica-condensation was decreased through 
the incorporation of lower concentration of BG. The polymer crosslinking, 
therefore, had the dominant role in the formation of gelatin-BG hybrid 
hydrogels and might control the degree of BG-condensation. 
The different concentrations of BG (0-2 µl/mg) were mixed with gelatin 
solution to physically crosslink the gelatin-BG hybrids. Despite the 
concentration of BG, the transparent hybrid hydrogels were formed after 10 
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min incubation at ambient temperature and no phase separation was 
observed. These hybrid hydrogels, moreover, have lost their physical 
integrities during the incubation at 37°C prior to assessing their 
physicochemical and mechanical properties. The lack of chemical bonding 
between interpenetrated gelatin-BG networks led to the rapid release of 
gelatin into solution and acquiring the fragile structure. 
Genipin as a biocompatible chemical crosslinking agent was used to form a 
gelatin-BG hybrid hydrogel. The distribution of silica within this hybrid 
hydrogel was monitored by electron microscopy. The SEM-EDS analyses in 
Figure  4-2 showed that silicate anions were homogeneously distributed 
within the gelatin-BG hydrogels. 
 
Figure  4-2 SEM image (A) and the distribution of Si ions (B) on the surface of genipin-
crosslinked gelatin-BG hybrid hydrogels. The scale bars represent 100µm.  
 
(B)
(A)
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The physicochemical properties of BG and pure hydrogels were 
significantly altered upon the formation of these hybrids. The incorporation 
of 1 µl/mg of BG into genipin-crosslinked hydrogels, for instance, 
significantly decreased the swelling ratio of pure hydrogels from 
7.15±1.59 mg/mg to 3.64±0.28 mg/mg. Data in Figure  4-3A show that 
further increase of BG concentration remarkably decreased the swelling 
ratio of hydrogels (p<0.001). This significant reduction was due to the 
intrinsic hydrophobic nature of BG, which had the water uptake capacity of 
0.35±0.01 mg/ml. These results were in the agreement with the literature 
where the conjugation of silica increased the hydrophobicity of gelatin 
powders by demonstrating the contact angle of ~45° [460].  
The formation of the interpenetrated gelatin-BG hybrid had a significant 
impact in the mechanical performances of hydrogels. As shown in 
Figure  4-3B, the compressive modulus of hydrogels, for instance, was 
significantly increased from 1.00±0.12 kPa to 26.67±6.31 kPa after 
incorporation of 2 µl/mg BG compared to pure gelatin hydrogels. The 
condensed silica network structurally reinforced the gelatin hydrogels upon 
van der Waals forces and the formation of hydrogen bonds between silanol 
functional groups of BG and free amines and/or carbonyl units of gelatin 
[461].  
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Figure  4-3 The effect of BG conjugation on swelling ratio (A) and compressive 
modulus (B) of genipin-crosslinked hybrid hydrogels. Data presented in * and *** 
represent p<0.05 and p<0.001, respectively. 
Despite the significant improvement on the mechanical properties of 
hydrogels, genipin-crosslinking did not significantly control the over-
condensation of the silica network. The results showed that when using 
genipin as a crosslinking agent, increasing the temperature significantly 
decrease the gelation time of hydrogels. For instance, the hydrogel was 
fabricated at 60°C after 30 min incubation of gelatin solution. At this 
condition, however, BG was condensed within 2 min. The significant effect 
of temperature on the hydrogel formation, the condensation of silica, and the 
differences between gelation time of BG and genipin-crosslinking resulted 
in the formation of brittle structures. These data implicitly suggested that it 
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was favourable to form the gelatin hydrogel prior to BG networking to 
overcome these limitations. 
4.4 Fabrication of a Photocrosslinked Gelatin-BG Hybrid 
Hydrogel 
The interpenetrated gelatin-BG hybrid hydrogels with different 
concentrations of BG were fabricated after 2 min UV-irradiation of gelatin-
BG solutions. The methacrylated derivative of gelatin (GelMA) was used to 
form a photocrosslinkable hydrogel in the presence of Irgacure as a 
photoinitiator. It was found that the pre-matured structures were formed 
immediately after the addition of 1.5 µl of BG per each mg of GelMA. It 
seems that the presence of methyl methacrylate groups in the structure of 
GelMA enhanced the hydrogen bond formation between silica and gelatin 
and thus facilitated the formation of pre-matured structure. Data in 
Figure  4-4 show that the conjugation of low concentration of BG 
(0.5 µl/mg) in GelMA hydrogels did not have significant effects on the 
physicochemical properties and mechanical performances of hydrogels 
(p>0.05). Incorporation of 1 µl/mg BG, on the other hand, significantly 
decreased the swelling ratio of hydrogels from 7.51±0.08 mg/mg to 
5.43±0.34 mg/mg.  
The interpenetration of the photocrosslinked hydrogel within BG network 
enhanced the mechanical performance of hydrogels. Data in Figure  4-4B 
show that these hydrogels could withstand under uniaxial cycles of 
compression-decompression. However, their energy loss were significantly 
increased by the incorporation of BG due to the intrinsic brittleness of silica. 
The addition of 1 µl/mg BG into pure GelMA hydrogels, for instance, 
significantly increased their energy loss from 23.44±4.86 % to 62.25±5.4 %. 
The compressive modulus of these hydrogels, as shown in Figure  4-4C, was 
improved from 39.44±4.86 kPa to 79.89±5.3 kPa upon interpenetrating of 
BG precursor (1 µl/mg) within their structure (p<0.001). 
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Figure  4-4 The effect of BG conjugation on swelling ratio (A), cyclic compression (B), 
compressive modulus (C) and energy loss (D) of photocrosslinked Gelatin-BG hybrid 
hydrogels. Data presented in *** represents p<0.001. 
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Despite the significant effect of photocrosslinking on controlling the 
condensation of BG, the interpenetrated network of gelatin-BG did not 
possess acceptable mechanical properties for bone tissue engineering due to 
the lack of covalent bonding between gelatin and BG.  
4.5 Summary 
This chapter described the formation of interpenetrated network of organic-
inorganic hybrid hydrogels upon the combination of the sol-gel method and 
polymer crosslinking. It was hypothised that polymer crosslinking prior to 
the condensation of BG was vital to eradicating the formation of brittle 
structures. In addition, external stimuli such as temperature and the 
isoelectric point of polymer and BG, the mechanism of polymer 
crosslinking, and the concentration of the inorganic component are the 
significant governing factors for tuning the formation of the interpenetrated 
networks. The mechanical performance and physicochemical properties of 
fabricated gelatin-BG were superior to BG. The problems associated with 
this method, however, was the insufficient mechanical strength of these 
hydrogels for bone tissue engineering applications. In the next chapter, the 
effect of using different organosilane coupling agents for covalent bonding 
of gelatin to BG would be examined. In addition, the impact of 
organosilation and further organic-inorganic hybrid formation on the 
physicochemical and mechanical properties of photocrosslinkable hydrogel 
would be discussed. 
  
 
Chapter 5. Fabrication of 
Covalently-Bonded Organic-
Inorganic Hybrid Hydrogels
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5.1 Introduction 
An interpenetrated network of gelatin-BG can be produced by the sol-gel 
method. In  Chapter 4, it was demonstrated that crosslinking of polymer 
phase has an impact on condensation of BG. Fast gelation of polymer phase 
expedited the condensation of BG and enhanced the mechanical strength of 
this interpenetrated structure. Among different method of crosslinking, the 
photocrosslinking was favourable as it controlled the condensation of BG 
and prevented the formation of brittle structure. The mechanical strength of 
GelMA-BG, however, was not within the acceptable range for bone tissue 
engineering. To address this shortfall, it was hypothesised that the formation 
of covalent bonds between GelMA and BG may enhance the mechanical 
strength and physical stability of these constructs. 
Different organosilane coupling agents have been selected for covalent 
bonding between the polymer and inorganic phases [408, 410, 462]. The 
fabricated hybrid, however, formed the brittle monolith due to the complete 
condensation of inorganic compounds through drying and aging steps [431]. 
In this chapter, the feasibility of organosilation of GelMA through different 
coupling agents and their mechanisms are investigated. The resulting 
functionalised GelMA was then chemically conjugated to BG to form a 
covalently bonded hybrid hydrogel. The effects of organosilation and hybrid 
formation on the physicochemical properties, mechanical strength, and the 
degradation behaviour of the resulting hybrids were then investigated. 
5.2 Organosilation of GelMA 
Different concentrations of GelMA (75-150 mg/ml) were functionalised 
with various organosilane coupling agents including APTES and GPTMS to 
form covalent bonds between gelatin backbone and BG. The organosilation 
reaction was accomplished in PBS (pH 7.4) at 40°C to control the hydrogel 
formation and gelation of BG. The hydrolysis of APTES and GPTMS 
liberated ethanol and methanol, respectively. The functionalisation of 
GelMA with organosilane was not feasible when using a high concentration 
of GelMA (150 mg/ml) due to the high viscosity of the solution. Therefore, 
Page | 63 
 
the lower concentrations of GelMA (75 mg/ml and 100 mg/ml) were used 
for this reaction. 
It was anticipated that by using APTES for GelMA functionalisation, the 
biological activity of this hydrogel is preserved due to the presence of this 
amine-coupling agent. The functionalisation occurs through direct 
condensation between amine groups of APTES and carboxylic acid groups 
of GelMA at 40°C for 20 h. However, the functionalisation of GelMA with 
APTES retard the gelation time of this hydrogel from 2 min to 10 min due 
to the steric hindrance effect of APTES chains and its interference with 
methacrylate group. This hydrogel, moreover, had lower structural integrity, 
and mechanical properties compared to neat GelMA.  
GPTMS was another organosilane coupling agent that was used to form a 
covalent bridge between GelMA and BG. GPTMS as a heterobifunctional 
agent undergoes competitive reactions between epoxy-ring hydrolysis and 
polycondensation of activated silanol groups. At 40°C and neutral pH, the 
kinetics of epoxide ring-opening reaction is slow [169]. The preliminary 
results showed that less than 14 h was not adequate for this reaction and 
above this period, there was a premature condensation of GPTMS. The 
faster self-condensation of GPTMS compared to APTES was due to the 
presence of methoxy pendant group in this coupling agent, which are more 
reactive than ethoxy functional groups of APTES [463]. The reaction time 
observed in this study was in agreement with the results of 29Si nuclear 
magnetic resonance (29Si-NMR) spectroscopy by Gabrielli et al. [464]. 
Their study confirmed that pure GPTMS is condensed after 16 h in neutral 
pH [464]. The presence of GPTMS had a negligible effect on the properties 
and gelation time of GelMA (Fn-GelMA) hydrogel. Therefore, GelMA was 
functionalised with GPTMS at 40°C for 14 h for the rest of the study. 
Glycidoxy functional group of GPTMS can form a covalent bond with 
either amine [395] or carboxylic acid [400] groups in amino acid residues of 
gelatin [465, 466]. The results of ATR-FTIR analyses in Figure  5-1A show 
the appearance of new bands at 970 cm-1 (silanol) and 1020 cm-1 
(methoxysiloxane) in Fn-GelMA, which endorsed the complete 
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functionalisation of GelMA with GPTMS [467]. These results, however, did 
not disclose the mechanism of organosilation. Colorimetric ninhydrin assay 
was therefore used to quantify the amine groups in Fn-GelMA hydrogels to 
determine the mechanism of GPTMS-functionalisation. The results show 
that the amount of the free amine functional group in GelMA was 15%, 
which was in agreement with 1H-NMR results [254]. However, the fraction 
of amine functional groups in GelMA was decreased to 13% following the 
functionalisation with GPTMS (p<0.001). This reduction of the percentage 
of free amine groups in Fn-GelMA confirmed that the glycidoxy functional 
groups of GPTMS formed covalent bonds with amine groups of GelMA 
during functionalisation reaction (Figure  5-2). The biological activity of 
GelMA might be slightly decreased due to decreasing the free amine groups 
[468]. 
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Figure  5-1 FTIR spectra of various hydrogels (A) the distribution of FITC-labelled 
amine groups (green) in Fn-GelMA hydrogel (B) and PLLA sample (C). PLLA was 
used as a positive control to show the absence of green fluorescence in this sample due 
to the absence of amine functional groups. The daggers and asterisks respectively 
represent to the presence and absence of amine functional groups. Scale bar 
represents 200 µm. 
(A)
(B)
* *
*
* *
*
†
†
†
†
†
(C)
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The presence of the free amine groups in the backbone Fn-GelMA was 
visualised with FITC. The strong and uniform fluorescence in Figure  5-1B 
confirms the presence of these sequence motifs within the structure of Fn-
GelMA hydrogels. The fabricated PLLA sample was also used as a positive 
control. Data in Figure  5-1C show that the PLLA sample did not illustrate 
any fluorescent light due to the absence of amine functional group in its 
structure. This result suggested the negligible impact of the partial reduction 
of the amine group on the biological activity of GelMA hydrogels. 
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Figure  5-2 The mechanism of organosilation of GelMA. 
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5.3 Physicochemical and Mechanical Properties of 
Functionalised GelMA Hydrogels 
The effect of GPTMS-functionalisation on the physicochemical properties 
and mechanical performance of hydrogels was studied. The molar ratio of 
2:1 between hydroxylysine, lysine and arginine amino groups of GelMA 
and organosilane coupling agents was chosen to preserve the biological 
activity of hydrogels. Data in Figure  5-3 show that the organosilation did 
not have a significant impact on swelling ratio and mechanical performance 
of hydrogels with a similar concentration of GelMA (p>0.05). On the other 
hand, increasing the concentration of GelMA significantly modified the 
physicochemical properties of hydrogels. The swelling ratio of Fn-GelMA 
hydrogels, for instance, was significantly decreased from 
12.32±0.36 mg/mg to 9.41±0.20 mg/mg by increasing the concentration of 
GelMA from 75 mg/ml to 100 mg/ml. The compressive modulus of the 
functionalised hydrogels, moreover, was remarkably enhanced from 
19.47±4.59 kPa to 42.39±3.58 kPa by increasing the concentration of 
GelMA (p <0.001). These results were in agreement with previous data 
presented by Nichol et al. who observed that by increasing the GelMA 
concentration the degree of crosslinking was increased [241]. Therefore, the 
swelling ratio of hydrogels decreases upon increasing the GelMA 
concentration while their compressive modulus increases [241]. 
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Figure  5-3 The effect of GPTMS-functionalisation on swelling ratio (A), Compression 
profile (B) and compressive modulus (C) of GelMA hydrogels with different 
concentration of GelMA. Data presented in *** represented p<0.001. 
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5.4 Fabrication of Fn-GelMA-BG Hybrid Hydrogels 
The covalently bonded organic-inorganic hybrid was fabricated by 
incorporation of BG precursors into an aqueous solution of Fn-GelMA. A 
preliminary test was performed to determine the concentration of BG 
(TEOS or TMOS) that could be used for chemical bonding with Fn-GelMA. 
The concentration of BG was changed from 0.25 to 1 µl/mg (µl of BG 
solution per mg of polymer). The hybridization reaction did not occur at low 
BG ratio (0.25 µl/mg). On the other hand, increasing the concentration of 
BG to 1 µl/mg led to the formation of the brittle structure due to the self-
condensation of silica networks. The BG ratio of 0.5 and 0.75 µl/mg were 
therefore used to fabricate the Fn-GelMA-BG hybrid hydrogels. 
The hybrid hydrogel was formed after 2 min UV crosslinking of the 
conjugated Fn-GelMA-BG solution in the presence of Irgacure. The 
chemical composition of BG precursors had a significant effect on the 
physicochemical properties of hydrogels due to the different steric 
hindrance and hydrolysis rates of their alkoxysilanes groups. The methoxy 
functional groups of TMOS, for instance, were hydrolysed 6-10 times faster 
than ethoxy functional groups of TEOS [463]. The higher hydrolysis rate 
and lower steric hindrance of these functional groups led to the faster 
condensation of TMOS, also expedited the covalent bonding with Fn-
GelMA and thus hybrid formation.  
The TMOS-based hybrid hydrogels showed brittle structures with 
insufficient swelling properties. For instance, the hybrid hydrogels 
fabricated from 100 mg/ml Fn-GelMA and 0.5 µl/mg TMOS displayed only 
2.91±0.1 mg/mg swelling ratio and 68.23±5.29 kPa compressive modulus. 
The further increase in the concentration of TMOS, as shown in Figure  5-4, 
did not have a significant effect on the physicochemical and mechanical 
properties of hydrogels. TEOS was therefore used as a BG precursor for 
chemical bonding with Fn-GelMA and formation of an Fn-GelMA-BG 
hybrid. 
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Figure  5-4 The effect of TMOS concentration on the swelling ratio (A) and 
compressive modulus (B) of Fn-GelMA-BG hydrogels. Data presented in *** 
represented p<0.001. 
The complete conjugation of Fn-GelMA and BG was confirmed by ATR-
FTIR spectra (Figure  5-1A). Upon the addition of BG and hybrid formation, 
the silanol band (at 970 cm-1) was shifted to 950 cm-1 and a new band was 
observed at 1150 cm-1 corresponding to silica structure [461, 469]. The 
distribution of silica within hybrid hydrogel structure was also monitored by 
SEM-EDS. The SEM image of Fn-GelMA-BG hybrid hydrogel is shown in 
Figure  5-5A. The homogeneous distribution of Si elements on the surface of 
this hybrid hydrogel was shown by SEM-EDS analysis as depicted in 
Figure  5-5B. The ATR-FTIR spectroscopy and SEM-EDS analyses 
confirmed the formation of a covalent bond between Fn-GelMA and BG, 
(A) ***
(B)
***
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and also the homogeneous distribution of BG on the surface of hybrid 
hydrogels. 
 
 
Figure  5-5 SEM image (A) and the distribution of Si ions (B) on the surface of Fn-
GelMA-BG hybrid hydrogels. The scale bars represent 500µm.  
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5.5 Physicochemical and Mechanical Properties of Fn-GelMA-
BG Hybrid Hydrogels 
The formation of the hybrid structure of Fn-GelMA and BG (i.e., TEOS 
solution) had significant impacts on the physicochemical and mechanical 
properties of hydrogels. Data in Figure  5-6A show that increasing Fn-
GelMA concentration did not have a significant effect on swelling ratio of 
hybrid hydrogels (p>0.05). Incorporation of BG into hydrogels, on the other 
hand, significantly decreased their swelling ratios due to increasing the 
degree of crosslinking and also the hydrophobic nature of BG (TEOS) [470, 
471]. For instance, the conjugation of 0.5 µl/mg BG into the hydrogels with 
75 mg/ml concentration of Fn-GelMA significantly decreased their swelling 
ratio from 13.16±1.0 mg/mg to 9.55±1.46 mg/mg. Further increasing the 
concentration of BG remarkably decreased the swelling ratio of hydrogels to 
2.21±0.16 mg/mg (p<0.001). 
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Figure  5-6 The effect of hybrid formation on swelling ratio (A), cyclic compression-
decompression (B), compressive modulus (C) and energy loss (D) of Fn-GelMA-BG 
hydrogels. Data reported as ** and *** represent p<0.01 and p< 0.001, respectively. 
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The effect of hybrid formation on the mechanical performance of hydrogels 
was evaluated to optimise the concentration of Fn-GelMA and BG. As 
shown in Figure  5-6B, hybrid hydrogels could withstand continuous cycles 
of compression-decompression without any deformations. The mechanical 
performance of hydrogels, moreover, was significantly enhanced by the 
conjugation of BG (Figure  5-6C) due to the formation of both covalent 
bonds and weak van der Waals interactions between Fn-GelMA and BG. 
The compressive modulus of hydrogels fabricated from 100 mg/ml Fn-
GelMA, for instance, significantly enhanced from 39.44±4.85 kPa to 
68.23±5.3 kPa upon the incorporation of 0.5 µl/mg BG. Further increasing 
the concentration of BG to 0.75 µl/mg remarkably elevated their 
compressive modulus to 96.08±5.28 kPa (p<0.01). Despite the significant 
increase in compressive modulus of hydrogels by hybrid formation, the 
presence of silica in their structure had a significant effect on their energy 
loss as depicted in Figure  5-6D. The incorporation of BG in 0.5 µl/m and 
0.75 µl/mg ratios into Fn-GelMA hydrogels (100 mg/ml), for instance, 
significantly increased the energy loss of Fn-GelMA hydrogels from 
23.28±2.16 % to respectively 52.39±2.74 % and 73.04±4.34 % (p<0.001).  
The outcomes of this study revealed that the concentration of BG has the 
paramount effect on the physicochemical and mechanical properties of 
hybrid hydrogels. The concentration of BG was kept below 0.5 µl/mg to 
minimise the risk of acquiring the brittle structure. Increasing the 
concentration of Fn-GelMA, on the other hand, significantly enhanced the 
mechanical properties of hydrogels, while their swelling ratio was not 
changed remarkably. The optimum hybrid hydrogel was therefore fabricated 
from 100 mg/ml Fn-GelMA and 0.5 µl/mg of BG. 
5.6 Degradation Profile of Hybrid Hydrogels 
5.6.1 The Accuracy of Analysis Method 
The gravimetric technique is an established method to determine the 
degradation profile of hydrogels [354, 448, 472]. This method, however, 
was not accurate in this study due to the poor structural integrity of GelMA 
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hydrogel that was used as a control sample. On the other hand, the possible 
precipitation of calcium phosphate particles on the surface of hybrid 
hydrogels could interfere with the actual mass of hydrogels. Hence, the 
mass loss ratio was not an accurate and practical method for monitoring the 
degradation profile of these hydrogels. The main components of the 
fabricated hybrid hydrogels were protein and silica. In here, the release of 
protein from the hybrid structures was measured to determine their 
degradation profiles.  
The degradation profiles of hydrogels were usually measured in phosphate 
buffer saline (PBS) to eliminate the effects of osmotic pressure between the 
hydrogel and its environment. The chemical composition of this media, 
however, differs from biological body fluids (Table  5-1). The ionic strength 
(mol/kg) of these media was calculated using 𝐼 = 1 2�  ∑ 𝑏𝑖 ×𝑛𝑖=1
𝑧𝑖
2 equation, where b and z represented the molarity and the charge of 
different ions in these media. Data in Table  5-1 show that the chemical 
composition and ionic strength of simulated body fluid (SBF), compared to 
the PBS, is closer to the human blood plasma. 
Particularly for bone tissue engineering, the in vitro bioactivity of scaffolds 
and formation of calcium phosphate particles are measured in SBF [473]. 
These differences between chemical composition and ionic strengths might 
have a significant effect on the in vitro performance of hydrogels. However, 
there is no study to evaluate the effect of incubating media on the 
degradation profile of hydrogels. 
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Table  5-1 Chemical composition of human blood plasma [474], simulated body fluid 
(SBF) [475] and phosphate buffer saline (PBS) [476] 
Ion Human Blood 
Plasma (mM) 
SBF (mM) PBS (mM) 
𝑯𝑯𝑶𝟑
− 27 4.2 - 
𝑲+ 5 5 2.7 
𝑯𝑪− 103 147.8 140.7 
𝑵𝑵+ 142 142 148 
𝑯𝑵+𝟐 2.5 2.5 - 
𝑴𝒎+𝟐 1.5 1.5 - 
𝑯𝑯𝑶𝟒
−𝟐 1 1 8.1 
𝑯𝟐𝑯𝑶𝟒
− - - 1.9 
𝑬𝑶𝟒
−𝟐 0.5 0.5 - 
Ionic Strength  0.150 (mol/kg) 0.160 (mol/kg) 0.163 (mol/kg) 
 
5.6.2 The Effect of Incubation Media on the Degradation of Hydrogels 
The effect of incubation media on the degradation profile of hydrogels in 
PBS and SBF was investigated. In both systems, as shown in Figure  5-7, the 
degradation rate of hybrid samples was lower than pure GelMA hydrogel. 
This significant stability and lower degradation were due to the formation of 
network structure between Fn-GelMA and BG [470]. The hybrid formation 
significantly decreased the amount of the released proteins (p<0.001) after 
14 days incubation in PBS from 92.92±2.74 % to 34.21±3.55 % for pure 
GelMA and hybrid samples fabricated from 0.5 µl/mg ratio of BG, 
respectively. 
As it was speculated, the incubation media had a significant effect on the 
degradation rate of hydrogels (p<0.001). For instance, the amount of the 
released proteins from hybrid hydrogel after one-day incubation was 
significantly decreased from 8.98±1.36 % to only 5.48±0.23 % by changing 
the media from PBS to SBF. This effect was due to the chemical 
compositions and ionic strength of these media [477]. Further incubation of 
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hybrid hydrogels revealed that only 22.26±0.85 % of their proteins was 
released after 14 days soaking in SBF. This amount was significantly lower 
than the cumulative amount of released proteins from hybrid hydrogels 
incubated in PBS in the same time point (34.21±3.55 %, p<0.001). Data in 
Figure  5-7 show that the hybrid formation significantly enhanced the 
integrity of gelatin hydrogel in the media and more than 60% of GelMA 
remained in hybrid hydrogels after 28 days incubation in SBF. The 
improvement in stability of the hydrogels is of great importance for in vitro 
regeneration of bone as Patterson et al. showed that osteoblasts formed 
more orientated structures on the scaffolds degraded within 6-8 weeks 
[478]. Therefore, it was concluded that the hybrid hydrogels formed with 
100 mg/ml Fn-GelMA and 0.5 µl/mg BG displayed the favourable 
degradation behaviour compared with pure GelMA hydrogels in different 
media.  
 
Figure  5-7 Degradation profile of various hydrogels in different media with respect to 
their protein release in particular days, G and H represent to GelMA and hybrid 
hydrogels fabricated with 100 mg/ml Fn-GelMA and 0.5 µl/mg BG, respectively. Data 
reported as *** p< 0.001. 
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The formation of the hybrid structure of Fn-GelMA and BG had significant 
impacts on physicochemical properties, degradation profile, and mechanical 
strength of the hydrogel. For a bone application, however, the scaffolds with 
the compression modulus higher than 300 kPa are favourable [479]. 
Increasing the methacrylation fraction, the concentration of GelMA and 
photoinitiator could increase the degree of crosslinking and thus improve 
the mechanical properties of hydrogels  
The effect of methacrylation fraction on the mechanical and biological 
properties of GelMA-based hydrogels was previously investigated [241, 
254]. It was found that upon the methacrylation, the free amine groups of 
gelatin formed a chemical bond to methacrylate groups [241]. Increasing the 
degree of methacrylation, therefore, enhanced the degree of crosslinking and 
elevated the mechanical properties of hydrogels. On the contrary, decreasing 
the biological motif sites of gelatin, i.e. free amine groups had a significant 
impact on the biocompatibility of GelMA hydrogels [254]. The degree of 
methacrylation of GelMA in this study was 80%. The further increase in the 
content of methacrylate might have a negative impact on the biological 
activity of hydrogels. 
The preliminary results showed that increasing the GelMA concentration led 
to the formation of premature silica network during the functionalisation 
process due to increasing the viscosity of the solution. Increasing the 
concentration of Irgacure, on the other hand, decreased the pore size of 
hydrogels and had significant drawbacks on biocompatibility and 
physicochemical properties of hydrogels [455-457]. Incorporation of 
GelMA hydrogel within prefabricated scaffolds is another approach to 
improving the mechanical properties [248]. The compressive modulus of 
these reinforced hydrogels, however, only depends on the concentration of 
GelMA. Therefore, this strategy was not used in this study to enhance the 
mechanical property of hybrid hydrogel.  
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5.7 Summary 
In this chapter, the feasibility of functionalised GelMA for chemical 
bonding to BG was examined. The favourable organosilane coupling agent 
was GPTMS due to complete functionalisation of GelMA. This 
organosilation reaction, moreover, did not interfere with crosslinking of the 
polymer phase. After this, the concentration of GelMA, GPTMS, and BG 
was optimised to acquire stronger mechanical strengths and suitable 
swelling properties compared to an interpenetrating hybrid of GelMA-BG. 
The hydrogels fabricated from 100 mg/ml GelMA functionalised with 
GPTMS, and 0.5 µl TEOS solution per each milligram of the organic 
component had superior properties. Despite the significant enhancement of 
physicochemical properties, mechanical strength, and degradation 
behaviours of these hydrogels their compressive modulus still was not 
adequate for bone tissue engineering. In the next chapter, a new approach 
would be proposed to enhance the mechanical properties of these hybrids. 
  
Chapter 6. Fabrication of 
Bioactive Hybrid Hydrogel 
for Bone Tissue Engineering
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6.1 Introduction 
The covalently bonded hybrid hydrogel with enhanced physicochemical 
properties and degradation behaviour was fabricated in  Chapter 5. The 
mechanical performance of these hydrogels was significantly enhanced by 
the formation of covalent bonds between Fn-GelMA and BG. Their 
compressive modulus, however, was still insufficient for bone tissue 
engineering. The aim of this study was to enhance the mechanical strength 
and stability of hybrid hydrogels. Several approaches including composite 
formation [480-482], double network formation [248, 483-485] and fibre 
reinforcement [486-488] have been attempted to improve the mechanical 
strength of hydrogels. The heterogeneous distribution of secondary phases 
within the hydrogel, however, is the paramount issue of these approaches. It 
was speculated that introducing a secondary crosslinking agent might have 
significant impacts on the mechanical strength and degradation profile of 
hybrid hydrogels. 
The feasibility of the formation of conjugated hybrid hydrogels with 
enhanced physicochemical properties and mechanical performances is 
investigated in this chapter. It is important to note that the secondary 
polymers should not interfere with organosilation reaction. Therefore, the 
absence of carboxylic acid and amine functional groups in their structures is 
the prerequisite criteria for the secondary crosslinking agents. The effect of 
the secondary polymer conjugation on the mechanical performance, 
physicochemical properties, degradation behaviour, and in vitro and in vivo 
biological performances of hybrid hydrogels are investigated. 
6.2 Fabrication of Natural-Based Photocrosslinkable Hybrid 
Hydrogel 
The photocrosslinkable derivatives of natural polymers such as alginate 
[232], chitosan [233, 489], Gellan gum [490], hyaluronic acid [227], and 
starch [491, 492] were extensively used to form a biocompatible hydrogel. It 
was speculated that the conjugation of these biopolymers into Fn-GelMA 
solution could enhance the mechanical properties and stability of hybrid 
hydrogels. A scaffold with enhanced mechanical properties, for instance, 
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has been fabricated using double network formation of GelMA and 
methacrylated derivative of Gellan gum [484]. The presence of carboxylic 
acid in the backbone of Gellan gum, however, could interfere with GelMA 
in organosilation reaction. The nucleophilic functional groups such as amine 
and carboxylic acid are found in the structure of other biopolymers 
including chitosan (amine), alginate and hyaluronic acid (carboxylic acid). 
Starch, on the other hand, only possesses electrophile functional groups (i.e. 
hydroxyl) in its structure. Therefore, the mechanical properties of GelMA-
BG hybrids might improve by conjugation of methacrylated derivative of 
starch (StaMA) within Fn-GelMA solution without any interference in 
GPTMS-functionalisation. Prior to the fabrication of bioconjugated hybrid 
hydrogels, the methacrylation process of starch was characterised. 
6.2.1 Characterisation of StaMA 
The effect of methacrylation on the chemical structure and thermal stability 
of starch was investigated. ATR-FTIR spectroscopy in Figure  6-1A 
confirms the synthesis of StaMA by the appearance of a characteristic band 
at 1670 cm-1 correspondence to alkenyl carbon (C=C) in its spectra [469]. 
The methacrylation, moreover, did not shift other characteristic bands of 
starch spectra. Data in Figure  6-1B show that the thermal stability of starch 
was significantly modified by methacrylation. The decomposition of 
StaMA, for instance, was initiated at 255°C, which was considerably lower 
than the decomposition temperature of pure starch (280°C).  
The slope of the thermogravimetric cure during decomposition period was 
calculated as a rate of decomposition [493]. It was found that the rate of 
decomposition was significantly improved from -0.287 (%/°C) to -0.128 
(%/°C) after methacrylation. The decomposition of StaMA was finished at 
305°C while more than 70% of StaMA remained untouched. On the other 
hand, 40% of the pure starch was remained after complete thermal 
decomposition at 310°C. These outcomes confirmed the complete 
methacrylation of starch.  
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Figure  6-1 The effect of methacrylation on ATR-FTIR (A) and TGA (B) of starch. 
The highest concentration of starch to form an aqueous solution is 
20 mg/ml. This concentration was therefore used to form a bioconjugated 
solution of StaMA and Fn-GelMA to form an organic-inorganic hybrid in 
the presence of BG. The temperature was set at 40°C to prevent over-
condensation of BG and also gelatinization of starch [494]. The presence of 
hydroxyl as an electron-donating group in the backbone of StaMA might 
form weak van der Waals interactions and hydrogen bonding with electron-
withdrawing functional groups of GelMA. StaMA, therefore, could entangle 
within GelMA chains and act as a filler to form a composite upon 
photocrosslinking. This hypothesis was evaluated by the formation of 
composite from 100 mg/ml GelMA and 20 mg/ml starch. It was found that 
UV irradiation of this solution did not form a hydrogel even after 10 min 
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due to the steric hindrance of starch molecules. The bioconjugation of 
20 mg/ml StaMA into GelMA solution, on the other hand, formed a 
hydrogel within 1 min UV irradiation due to increasing the degree of 
photocrosslinkable functional groups. 
The presence of MA functional groups in the structure of StaMA could form 
a chemical bond with other MA groups in StaMA and GelMA chains. The 
formation of these chemical bonds forms a crosslinked structure or an 
interpenetrated polymer network (IPN) with GelMA solution. The specific 
clarification between these two networks (i.e., crosslinked or IPN) was not 
possible due to the appearance of similar functional groups in FTIR-ATR of 
GelMA-StaMA hydrogels (data not shown). In this study, therefore, the 
term of bioconjugation was used to covering both crosslinking and IPN 
formation in GelMA-StaMA hydrogels. 
6.2.2 Physicochemical and Mechanical Properties of Bioconjugated 
Hybrid Hydrogels 
The effects of StaMA bioconjugation on the physicochemical properties and 
mechanical performance of GelMA hydrogels are shown in Figure  6-2. It 
was found that the bioconjugation of StaMA significantly decreased the 
swelling ratio of GelMA hydrogels from 9.92±0.42 mg/mg to 
6.25±0.9 mg/mg (p<0.001) due to increasing the degree of crosslinking. The 
incorporation of BG solution (0.5 µl per each milligram of Fn-GelMA and 
StaMA) into these hydrogels significantly decreased their swelling ratio to 
4.06±0.6 mg/mg due to intrinsic hydrophobicity of silica and formation of 
more compact structures. 
Despite the significant decrease in the swelling ratio of bioconjugated 
hybrid hydrogels, their mechanical performances were remarkably 
enhanced. The Fn-GelMA-StaMA-BG hydrogels, as shown in Figure  6-2B, 
could withstand the uniaxial cycles of compression-decompression loads 
without deformation. The compressive modulus of hydrogels, moreover, 
was enhanced 1.7-fold upon StaMA conjugation. Further incorporation of 
BG into bioconjugated hydrogel significantly improved its compressive 
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modulus from 67.57±1.96 kPa to 198.75±24.2 kPa (p<0.001). The previous 
outcomes in  Chapter 5 showed that the hybrid formation had a significant 
effect on the energy loss of pure GelMA hydrogels. The further 
bioconjugation of StaMA within these hydrogels significantly increased 
their energy loss (p<0.001). The hybrid formation, however, did not have 
significant impacts on the energy loss of the bioconjugated hydrogels. The 
energy loss of all hydrogels, as shown in Figure  6-2D, was less than 50% 
that underpin the elasticity of all hybrid hydrogels [495].  
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Figure  6-2 The effect of StaMA bioconjugation and hybrid formation on swelling ratio 
(A), cyclic compression-decompression (B), compressive modulus (C), and energy loss 
(D) of GelMA-based hydrogels. Non-Hybrid refers to polymeric hydrogels without 
organosilation. Data presented as *** represented p<0.001.  
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Despite the significant improvements on the physicochemical and 
mechanical properties of hybrid hydrogels upon StaMA conjugation, the 
further modification of these complexes was restricted due to the limited 
solubility of starch in PBS. Therefore, another photocrosslinkable polymer 
was conjugated to Fn-GelMA-BG hybrid hydrogels to enhance their 
physicochemical and mechanical performances. 
6.3 Conjugation of PEGDA within GelMA Hydrogels 
The application of poly(ethyleneglycol) diacrylate (PEGDA) as inert 
biomaterials in hydrogel formation is widespread due to its hydrophilic 
nature and tailorable physicochemical and mechanical properties [496-503]. 
The lack of nucleophilic functional groups in the structure PEGDA prevents 
any interfere with organosilation of GelMA. Different concentration of 
PEGDA, therefore, was conjugated within the GelMA-based hydrogel, and 
their physicochemical and mechanical properties were studied. Data in 
Figure  6-3A show that the swelling ratio of hydrogels was significantly 
decreased upon the conjugation of PEGDA within their structures 
(p <0.001) due to increasing the degree of crosslinking [471]. Conjugation 
of 50 mg/ml PEGDA to GelMA solution, for instance, significantly 
decreased the swelling ratio of hydrogels to 7.26±0.34 mg/mg. The further 
increasing in the concentration of PEGDA to 200 mg/ml in conjugated 
hydrogels remarkably decreased their swelling ratio to 2.83±0.08 mg/mg 
(p<0.001). 
Despite the remarkable decrease in swelling ratio of conjugated hydrogels, 
their mechanical performances were significantly improved. It was found 
that elevating the concentration of PEGDA from zero to 50 mg/ml, and 
100 mg/ml increased the mechanical strength of these conjugated hydrogels 
by five- and seven-fold, respectively. The conjugated hydrogel with 
50 mg/ml concentration of PEGDA, for instance, displayed elastic 
performances under uniaxial cycles of compression-decompression and 
possessed the compressive modulus of 211.16±14.2 kPa (Figure  6-3B and 
C). The further increasing of the concentration of PEGDA significantly 
enhanced the compressive modulus of hydrogels to 342.97±17.3 kPa.  
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The conjugation of PEGDA also had a significant effect on the mechanical 
properties of hydrogels. The addition of 50 mg/ml PEGDA to GelMA, for 
instance, significantly increased the energy loss of hydrogels from 
23.27±4.32 % to 38.67±1.4 %. This effect might be due to the random 
conjugation of PEGDA chain within GelMA network. Further increase of 
PEGDA concentration, as shown in Figure  6-3C and D, remarkably 
decreased the energy loss of hydrogels. The conjugation of 200 mg/ml 
PEGDA into GelMA solution, as an example, led to the formation of an 
elastic hydrogel with a compressive modulus of 1181.71±394.8 kPa and 
17.41±1.8 % energy loss. 
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Figure  6-3 The effect of PEGDA concentration on swelling ratio (A) cyclic 
compression-decompression (B), compressive modulus (C) and energy loss (D) of 
conjugated GelMA hydrogels. Data presented in *** represented to p<0.001. 
(C)
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***
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***
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The previous outcomes in  Chapter 5 revealed that the hybrid formation was 
the prosperous method to enhance the compressive modulus of hydrogels. 
The swelling ratios of those hybrid hydrogels, however, were significantly 
decreased due to the hydrophobic nature of BG and also increasing their 
degree of crosslinking. The concentration of PEGDA in conjugated 
hydrogels, therefore, must be optimised prior to the incorporation of BG and 
the hybrid formation. Despite the significant improvement in the mechanical 
performance of hydrogels, conjugation of high concentration of PEGDA 
significantly decreased the swelling ratio of hydrogels. The lower 
concentrations of PEGDA (50-100 mg/ml) were therefore conjugated within 
Fn-GelMA to form an organic-inorganic hybrid with proper swelling ratio 
properties.  
6.4 Fabrication of Photocrosslinkable Hybrid Hydrogels with 
Enhanced Physicochemical and Mechanical Properties 
The effects of hybrid formation on the swelling ratio and mechanical 
performance of PEGDA-conjugated hydrogels were investigated. As it was 
expected, the swelling ratio of hydrogels dramatically decreased upon 
incorporation of BG (p<0.01). Data in Figure  6-4A reveal that the swelling 
ratio of hydrogels conjugated with 50 mg/ml PEGDA was significantly 
decreased from 7.26±0.34 mg/mg to 4.35±0.44 mg/mg after hybrid 
formation. Increasing the concentration of PEGDA in the hybrid hydrogel, 
however, did not significantly decrease their swelling ratio (p>0.05).  
Upon the incorporation of BG, the compression modulus of PEGDA-
conjugated hydrogels was further increased by 1.5-fold. These results 
endorsed that regardless of PEGDA concentration, the formation of the 
silica network reinforced the compressive modulus of hydrogels. For 
instance, the fabricated hybrid hydrogel from 100 mg/ml PEGDA displayed 
the compression strength of 528.9±32.67 kPa that was within the acceptable 
range for bone regeneration applications [479]. The compression strength of 
this hybrid hydrogels is remarkably higher than previously developed 
interpenetrated polymer network (IPN) hydrogels from GelMA and PEGDA 
[235, 254, 256]. For instance, the IPN hydrogel fabricated from similar 
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concentrations of GelMA and PEGDA using thiol click chemistry technique 
showed the compressive modulus of 80 kPa [235]. The conjugation of poly 
(lactide-co-ethylene oxide-co-fumarate) (PLEOF) and PEGDA was another 
attempt to improve the mechanical properties of GelMA hydrogels [254]. 
The hydrogel fabricated from 300 mg/ml PLEOF, 100 mg/ml PEGDA and 
100 mg/ml GelMA possessed the compressive modulus of 250 kPa that was 
lower than hybrid hydrogels fabricated in this study. In addition to 
enhancement of compressive modulus of hydrogels, the energy loss of 
conjugated hydrogels was increased upon hybrid formation. The energy loss 
of all hybrid hydrogels, as shown in Figure  6-4D, was less than 50% that 
underpins their elasticity [495]. 
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Figure  6-4 The effect of PEGDA conjugation and hybrid formation on swelling ratio 
(A), cyclic compression-decompression (B), compressive modulus (C) and energy loss 
(D) of GelMA-based hydrogels. Non-Hybrid refers to polymeric hydrogels without 
organosilation. Data presented in ** and *** represented to p<0.01 and p<0.001. 
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The results of this study in  Chapter 5 showed that the degradation profile of 
hydrogels was a function of incubation media. It was hypothesised that the 
incubation media also has a significant impact on the mechanical 
performance of hydrogels. The GelMA-based hydrogels were prepared in 
PBS solution and their mechanical properties in this media were shown in 
Figure  6-4. The ultimate application of these hydrogels is bone tissue 
engineering. In order to stimulate the physiological environment of the 
bone, these hydrogels were incubated in SBF at 37°C. The presence of 
inorganic compounds in the structure of hybrid hydrogels acted as a 
nucleation site and thus could enhance the precipitation of ionic components 
on the surface of hydrogels [504]. Hence, the topography of hydrogels 
would change upon the sedimentation of ionic compounds that further alters 
the mechanical performances of hybrid hydrogels. No attempt, however, has 
been approached to investigate the effect of incubation media on the 
mechanical performance of hydrogels. 
6.5 The Effect of Incubation Media on Mechanical Properties of 
Hydrogels 
Different concentrations of PEGDA were conjugated within GelMA-based 
hydrogels before and after hybrid formation, and all hydrogels were 
incubated in SBF media at 37°C. The effects of media incubation, PEGDA 
conjugation, and hybrid formation on the mechanical properties of 
hydrogels, therefore, were specifically distinguished. As shown in 
Figure  6-5A, the compressive modulus of hydrogels was significantly 
decreased upon incubating in SBF (p<0.001). The continuous decrease in 
the compressive modulus of hydrogels was in agreement with the results of 
Jeon et al. while their photocrosslinked alginate hydrogels lose their 
compressive moduli in deionised water over time [232].  
The compressive modulus of pure GelMA hydrogels, for instance, 
decreased from 39.44±4.85 kPa to 29.23±2.3 kPa after one-day incubation 
in SBF. The compressive moduli of other hydrogels were similarly 
decreased after 1 day incubation that was due to the osmotic pressure 
between hydrogels and SBF. Further incubation of hydrogels in SBF media 
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significantly decreased their compressive moduli (p<0.001). The pure 
GelMA, for instance, possessed 19.59±2.90 kPa compressive modulus after 
3 days incubation in SBF. The seven days incubated GelMA hydrogels lost 
their physical integrity during the compression test, and thus their 
compressive moduli were excluded.  
The previous data in  Chapter 5 revealed that 20.38±1.6 % and 
36.02±4.18 % of proteins were released from pure GelMA hydrogel within 
respectively 3 and 7 days incubation in SBF. The bulk hydrolysis of 
hydrogels, therefore, was the particular aspect on decreasing of mechanical 
properties of GelMA hydrogels overtime. 
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Figure  6-5 The Compressive modulus and energy loss of GelMA-PEGDA hydrogels 
after incubation in SBF at different times G and P represented to GelMA and 
PEGDA, respectively. Data reported as *** p < 0.001. 
The mechanical properties of GelMA-PEGDA hydrogels displayed similar 
trend with pure GelMA hydrogels as depicted in Figure  6-5A. For example, 
the hydrogels contained 50 mg/ml PEGDA significantly lost their 
compressive modulus from 211.16±7.09 kPa to 71.46±22.32 kPa after 
3 days incubation in SBF. The compressive modulus of these hydrogels was 
dramatically decreased to 4.89±.038 kPa after 7 days incubation in SBF. It 
was concluded that mechanical strength was gradually decreased due to the 
degradation of hydrogels. 
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Increasing the concentration of PEGDA had a significant impact on the 
mechanical stability of these hydrogels. After 7 days incubation in SBF, for 
instance, the 100 mg/ml PEGDA-conjugated hydrogels displayed the 
compressive modulus of 100.87±22.64 kPa which was significantly lower 
than its modulus prior SBF-incubating (342.98±15.42 kPa, p<0.001).  
Despite the significant effect of incubating media on the compressive 
modulus of conjugated hydrogels, the SBF incubation up to 3 days did not 
have a remarkable impact on the energy loss of GelMA-PEGDA hydrogels 
(p>0.05). Data in Figure  6-5B show that these hydrogels kept their elastic 
performance under cycles of compression-decompression loads, while their 
energy loss was less than 50 % after 3 days incubation in SBF. After 7 days 
incubation in SBF, however, these hydrogels could not withstand under 
cyclic compression-decompression loads. It was concluded that the 
mechanical properties of hydrogels were a factor of incubating media and 
the period of incubation.  
The mechanical stability of hydrogels over time is a crucial factor for bone 
tissue engineering since the callus formation in a bone defect site is a 
protracted process and begins 7 days post-culture [505]. The hybrid 
formation significantly improved the mechanical stability of hydrogels over 
time (Figure  6-6). Prior to conjugation of PEGDA, for instance, the Fn-
GelMA-BG hybrid hydrogels kept their mechanical stability after 7 days 
incubation in SBF. Their compressive modulus was continuously decreased 
from 70.18±4.56 kPa to 58.06±1.46 kPa and 40.18±0.96 kPa after 
respectively 1 and 7 days incubation. These hydrogels, however, lost their 
physical integrities under the compression loads after 14 days incubation in 
SBF. Similar to non-hybrid hydrogels, the osmotic pressure and bulk 
degradation of these hybrid hydrogels were the main aspects on the 
continuous decrease of their mechanical performances.  
The bioactive scaffold with continuous mechanical stability was fabricated 
by conjugation of PEGDA within the hybrid hydrogels. Data in Figure  6-6A 
demonstrate that the conjugated hybrid hydrogels contained 100 mg/ml 
PEGDA displayed an elastic performance with a compressive modulus of 
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101.66±6.82 kPa after 7 days incubation in SBF. These hydrogels, 
moreover, represented the compressive modulus of 51.09±13.68 kPa after 
21 days incubation in SBF, which is still favourable for osteoblasts to 
proliferate [506]. The conjugated hybrid hydrogels with a lower 
concentration of PEGDA (50 mg/ml), on the other hand, lost their 
mechanical stability over time. These hydrogels displayed 1.37±0.84 kPa 
compressive modulus after 7 days incubation in SBF (Figure  6-6B). 
Regardless the concentration of PEGDA, the elastic performance of all 
conjugated hybrid hydrogels was confirmed by measuring their energy loss. 
Data in Figure  6-6C show that the energy loss of all hydrogels did not 
significantly change during SBF incubation.  
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Figure  6-6 The Compressive modulus(A and B) and energy loss (C) of Fn-GelMA-
PEGDA-BG hybrid hydrogels after incubation in SBF at different times. G, P and H 
represented to Fn-GelMA, PEGDA and Hybrid hydrogel, respectively. Data reported 
as ** p < 0.01 and *** p < 0.001. 
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The comparison between these outcomes revealed that the introducing the 
secondary polymer into hybrid hydrogels significantly increased their 
degree of crosslinking. The hybrid hydrogel with a higher concentration of 
PEGDA, for instance, demonstrated the highest mechanical stability over 
time. The swelling ratio of hydrogels, on the other hand, was remarkably 
decreased by PEGDA conjugation. Their swelling ratio, however, was still 
in the acceptable range for biomedical applications including bone 
regeneration or controlled release of pharmaceutically active proteins [507-
510]. The results of this study demonstrated that 100 mg/ml PEGDA was 
sufficient to achieve the desirable mechanical strength and also swelling 
property of hybrid hydrogels. 
6.6 Physical Stability of Conjugated Hybrid Hydrogels 
Previous outcomes in  Chapter 5 showed that regardless the chemical 
composition of incubation media, the physical stability of hydrogels was 
enhanced by hybrid formation. The similar chemical composition of SBF, 
moreover, stimulated the degradation of hydrogels in body fluid. The 
degradation profile of conjugated hybrid hydrogels was therefore 
investigated in SBF media with respect to the cumulative degree of released 
proteins and silicate ions from these hydrogels.  
The conjugated hybrid hydrogels were fabricated from GelMA, PEGDA, 
and BG. The degradation profile of PEGDA chains has been investigated 
in vitro [511] and in vivo [512]. It was found the molecular weight of 
PEGDA has a significant impact on the hydrolytic resorption of PEGDA 
[513]. In this study, low-molecular weight PEGDA (Mn= 700) was used. 
Therefore, it can be exerted from the body through metabolism and show a 
minimal impact on the biocompatibility of hybrid hydrogels [514]. The 
amounts of released protein and silicate anions were therefore quantified to 
determine the profile of degradation of hydrogels.  
It was found that the conjugation of PEGDA into GelMA hydrogels 
dramatically enhanced their structural integrity. Data in Figure  6-7A show 
that the protein release from GelMA hydrogels after seven days incubation 
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in SBF was decreased from 36.02±2.09 % to 25.86±0.90 % by conjugation 
of 100 mg/ml PEGDA within their structure (p<0.05). The hybridization of 
the hydrogel with BG further enhanced their structural stability and caused a 
2-fold decrease in the protein release. The protein release from hybrid 
hydrogel was only 11.92±1.72 % after seven days, which confirmed their 
high structural stability and protein retention capacity.  
Previous studies showed that the retention of proteins within the structure of 
hydrogels is essential to acquire favourable biological responses for a long-
term in vitro [131, 135, 232]. After 21 days, nearly 75% of GelMA was 
maintained within the structure of hybrid hydrogel due to chemical bonding 
between GelMA and BG that reduced the degradation rate of gelatin. 
Indeed, this enhancement of structural stability was remarkably higher than 
previous studies that attempted different approaches for preserving GelMA 
in hydrogel structure. For instance, at the same period, it was reported that 
more than 45% of GelMA was leached out from IPN hydrogel fabricated 
from GelMA, PLEOF and PEGDA [254]. Therefore, the presence of silica 
network structure in these hybrid hydrogels has a paramount role in 
enhancing the physical integrity of hydrogel.  
The amount of silicate anions released from hybrid hydrogels in SBF was 
monitored to assess their degradations. As shown in Figure  6-7B, the 
conjugation of PEGDA in hybrid hydrogels did not have a significant 
impact on degradation of silicate anions (p>0.05). For instance, less than 
1.2 % of silicate anions were released from hybrid hydrogels after 28 days 
incubation in SBF. The substantial integrity of silica within hybrid 
hydrogels could enhance the bioactivity of hydrogels; hence, it promotes the 
precipitation of calcium phosphate particles on the surface of hydrogels for 
a longer period.  
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Figure  6-7 The cumulative protein release (A) and cumulative silicate degradation (B) 
from different hydrogels. G, P and H represent to GelMA (100 mg/ml), PEGDA (100 
mg/ml) and Hybrid (0.5 µl/mg BG), respectively. Data presented in *** represents 
p<0.001. 
6.7 In vitro Bioactivity of Conjugated Hydrogels 
The in vitro bioactivity of hybrid hydrogels was assessed upon soaking 
these hydrogels in SBF media at 37°C. The pure GelMA hydrogel as a 
control was incubated in the similar condition. The results of SEM-EDS 
microscopy in Figure  6-8 revealed that no calcium (Ca) or phosphate (P) 
ions were precipitated on the surface of GelMA hydrogels. However, the 
results in Figure  6-9 shows the presene of Ca and P ions on the similar 
position of the surface of hybrid. The calcium phosphate (Ca-P) particles 
were therefore formed on the surface of hybrid hydrogels. The presence of 
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silanol functional groups in these hydrogels acted as the nucleation sites and 
thus enhanced the precipitation of Ca-P particles from SBF solution on their 
surfaces [504]. The distribution of Ca and P particles on the surface of 
hybrid hydrogels after 21 days SBF incubation at 37°C is shown in 
Figure  6-8. Moreover, it was found that the ratio of Ca to P ions in the 
precipitated particles was increased over time and approached 1.84±0.15 
after 21 days incubation in SBF. This ratio was not further increased 
significantly, and it was close to Ca/P ratio in a typical adult female bone 
(1.71) [515]. 
 
Figure  6-8 SEM image (A) and the distribution of Ca ions on the surface of GelMA 
hydrogel after 3 weeks incubation in SBF at 37°C. Scale bar represents 500 µm  
(A)
(B)
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Figure  6-9 SEM image (A), the distribution of calcium (B) and phosphate (C) particles 
on the surface of hybrid after 3 weeks incubation in SBF at 37°C, and the ratio of 
precipitated Ca-P particles on the surface of Fn-GelMA-PEGDA-BG hybrid 
hydrogels in different time (D). Data presented in *** represented p<0.001. Scale bars 
represent 500 µm.  
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6.8 In vitro Cell Studies 
The precipitation of Ca-P particles on the surface of hybrid hydrogels can 
promote the proliferation of osteoblasts. This hypothesis was studied by 
comparing the proliferation and alkaline activity of osteoblasts on the 
surface of pure GelMA and hybrid hydrogels for up to 28 days. The 
confocal laser scanning microscopy (CLSM) images (Figure  6-10A and B) 
revealed that the viability of osteoblast cells was significantly improved on 
the surface of hybrid hydrogels. This enhancement was due to the stiffness 
improvement of hybrid hydrogels and more importantly the precipitation of 
Ca-P particles on their surfaces as the two main components of natural bone 
extra cellular matrix. The CLSM images also revealed that the osteoblast 
cells diffused within hydrogels. Three-dimensional conversion of CLSM 
images (Figure  6-10C) showed that the Saos-2 cells lost their vitality upon 
diffusing within GelMA hydrogels 28-days post-seeding. The viability of 
the diffused cells within hybrids, however, was remarkably enhanced, and 
the cells proliferated progressively through these hydrogels (Figure  6-10D). 
Despite the evaluation of vitality and proliferation of osteoblasts, their 
phenotype was also examined upon alkaline phosphatase assay (ALP). 
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Figure  6-10 Proliferation of osteoblast cells cultured on the surface of GelMA (A) and 
hybrid (B) hydrogels after 14 days (scale bar=50 µm) and their diffusion within 
GelMA (C) and hybrid (D) hydrogels 28-days post-culturing. Cells were stained using 
PI (red) and DAPI (cyan) and images were analysed using Fiji-ImageJ software. 
The release of ALP from osteoblasts is the well-known assay to assess their 
osteogenic phenotypes. As shown in Figure  6-11, the ALP activity of the 
cells on the hybrid GelMA-PEGDA-BG structures was significantly higher 
than GelMA hydrogels (p<0.001). In addition, the cultured cells on the 
surface of hybrids kept their phenotypes at least for 21 days since their 
alkaline phosphatase activity was significantly increased over time. This 
result confirmed that the chemical conjugation of BG imparted 
osteoconductivity behaviour to the hydrogel structures. 
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Figure  6-11 The alkaline phosphatase activity (ALP) of cells cultured on the surface of 
different hydrogels. Data presented as ** and *** respectively represent p<0.01 and 
p<0.001. 
6.9 In vivo Animal Study 
The in vivo cytocompatibility, degradation and the biological properties of 
hybrid hydrogels were studied by using mice-subcutaneous implantation 
model. These hydrogels were pre-fabricated in vitro by photocrosslinking of 
100 mg/ml Fn-GelMA with 100 mg/ml PEGDA covalently bonded to 0.5 µl 
of BG per each milligram of polymer content, in the presence of Irgacure. 
The surgeries were accomplished in ANZAC Research Institute in Concord 
Hospital with direct assistance of Dr. Yiwei Wong.  
Nine pathogen-free, male mice, aged 6 months were acquired, housed, and 
studied under a protocol approved by SLHD Animal Welfare Committee in 
Sydney, Australia (2013/019A). After the surgery, in the period of the test 
for 4 weeks, the animal behaviour was monitored for signs of pain/distress, 
restlessness, depression, and lack of appetite. Heart and respiratory rates, 
body temperature, and their activities were also monitored. The mice 
maintained their well-being throughout the period of study. All wounds 
healed favourably by secondary intention and with no scarring. Regular and 
comfort movements of mice were noticed in the housing facility.  
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At different time points, up to 4 weeks post-surgery, the hybrid hydrogels 
were successfully excised. It was found that the explanted hydrogels 
retained their shapes and structures for more than four weeks. The in vivo 
degradation profile of these hydrogels also confirmed that hybrid formation 
has a significant impact on their in vivo stability. The pure GelMA hydrogel, 
for instance, lost its integrity after two weeks subcutaneously implantation 
in mice [516, 517]. The magnetic resonance imaging (MRI) of 
subcutaneously implanted PEGDA hydrogels, moreover, confirmed that 
these hydrogels lost more than half of their volume after 25 days 
implantation [518]. The in vivo resorption profile of hybrid hydrogels 
revealed that their physical stability was significantly enhanced by hybrid 
formation, which was in agreement with their in vitro degradation profile in 
SBF. 
At different time points, the implanted hydrogels were successfully excised 
and underwent histology analyses. During the slide preparation for H&E 
staining, however, the hydrogels were washed away due to the prolonged 
ethanol washing cycles, e.g. 24 hours. Therefore, an empty gap was formed 
at the implantation site, as shown in Figure  6-12. An inflammatory response 
towards the hybrid hydrogels was observed during the first two weeks of 
implantation due to the formation of fibrotic tissues around the hybrids. It 
was found that the enormous foreign body giant cells (FBGC) were formed 
around the implanted hydrogels 1 week post-implantation. The extension of 
FBGCs, however, was significantly decreased up 14 days. This 
immunogenic response was due to the presence of PEGDA in the hybrid 
hydrogels since the MRI monitoring has confirmed the poor integration and 
rapid resorption of this polymer [518]  
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Figure  6-12 H&E staining of implants after one (A), two (B) and four (C) weeks post-
implantation with the scale bar of 100 µm. The progress of fibrotic tissues around the 
implanted hydrogels after different time points are illustrated in higher magnification 
(scale bars represent 200 µm). The white arrows and asterisks respectively represent 
to foreign body giant cells and lamina propria. 
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In the period of two to four weeks post-operation, the immune response to 
the hybrid hydrogels was settled, as the fibrotic tissue around the implanted 
hydrogel was significantly decreased after 2 weeks. The histological 
analyses of the implanted hydrogels with their surrounded tissues were 
shown in Figure  6-12 A-C. In addition, the observed FBGCs was 
completely diminished after four weeks (the white arrows in Figure  6-12). 
The presence of lamina propria was another sign of inflammatory within the 
first couple of weeks post-implantation. These loose connective tissues 
contain various cell types including fibroblasts, lymphocytes, plasma cells, 
and macrophages to form the fibrotic tissue around the implanted hydrogels 
(white asterisks in Figure  6-12). This drop of lamina propria after four 
weeks implantation revealed that the hybrid hydrogels did not cause chronic 
inflammation.  
One possible explanation for these behaviours is the chain relaxation 
behaviour of gelatin at physiological condition resulting from coil-to-triple 
helix conformation changes to promote its biocompatibility [519, 520]. The 
presence of bioactive glass on these hybrid hydrogels, moreover, have 
significant impacts on their interfacial reactions with surrounding tissue 
[330]. The formation of Ca-P particles on the surface of these hybrids, 
therefore, could promote the formation of ECM and improve the 
biocompatibility of hydrogels. The in vivo results of this study completely 
confirmed the accuracy of in vitro degradation profile of hybrid hydrogels in 
SBF and their biocompatibility towards different tissues and cell types. In 
addition to significant impacts of bioactive hybrid hydrogels on proliferation 
of osteo-progenitor cells and thus bone regeneration, the presence of GelMA 
in the backbone of these hybrids may promote the proliferation of soft 
tissues. The interface of soft-to-hard tissues therefore might be mimicked 
upon the fabrication of bioactive hydrogel with gradient of mineralisation.  
6.10 Fabrication of Bioactive Hybrid Hydrogel with Gradient of 
Mineralisation 
The shortcomings of current fixation methods for ligament reconstruction 
are insufficient mechanical stability [521], and the formation of non-
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mineralised soft tissue within the bone tunnel [522]. It is critical to 
developing a new approach to addressing these issues and minimise the risk 
of failure of current ligament replacement at interface. To this end, a 
bioactive hydrogel with gradient of mineralisation was fabricated from 
GelMA that was covalently bonded with bioactive glass to mimic the 
structure of ligament interface. The optimum concentrations of GelMA, 
PEGDA, and BG were used to embed a silk fabric, as a ligament 
reconstruction graft, within the resulting scaffold. The physical integrity of 
these structures was tested for the ligament-to-bone interface tissue 
engineering. 
6.10.1 Fabrication of Bioactive Hybrid Hydrogel with Gradient of 
Mineralisation 
A bioactive hydrogel with gradient of mineralisation was fabricated that 
composed of three regions. This gradient hydrogel was fabricated in a 
custom-made mould that consisted of a removable slab made from 
poly(dimethyl siloxane) (PDMS). As shown in Figure  6-13, the slab was 
firstly inserted in the middle of the mould to form two distinct zones. In 
each run 1 mg/ml Irgacure was added as a photoinitiator for the fabrication 
of GelMA-PEGDA-BG hydrogel network. Different colour dyes were used 
for separate parts to demonstrate the integration of different regions. As 
shown in Figure  6-13, after filling the solution at two end parts, the mould 
was kept at -20°C to form physically crosslinked hydrogels. The PDMS slab 
was then removed from the mould, and the hybrid solution of GelMA-BG 
was poured between the physically crosslinked hydrogels at room 
temperature. The mould was then transferred under UV light to form a 
bioactive scaffold with gradient of mineralisation. 
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Figure  6-13 The procedure for fabrication of bioactive scaffold with gradient of 
mineralisation 
The bioactive hydrogel with gradient of mineralisation was fabricated from 
the optimum concentrations of GelMA, PEGDA, and BG. As shown in 
Figure  6-14A, these materials were fully integrated within their boundaries 
and formed a unique structure with a gradient of chemical composition. The 
physical integrity of this bioactive hydrogel was qualitatively evaluated 
under different mechanical loads. As shown in Figure  6-14B, the gradient 
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hydrogel could withstand under bending loads without any deformation. 
The effect of elongation on the physical integrity of the gradient hydrogel 
was also examined. To this end, the hydrogels were fixed within the 
pneumatic grips and underwent tensile load with a rate of 0.05 mm/min in 
the hydrated state at 37°C. As shown in Figure  6-14C, the gradient hydrogel 
did not lose its physical integrity from its boundaries under the elongation 
loads.  
 
Figure  6-14 The fabricated bioactive scaffold with a gradient of mineralisation (A) 
and its physical integrity under bending (B) and elongating loads (C). Arrows indicate 
the integration of hydrogels in their boundaries. 
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The formation of bioactive hydrogel with gradient of mineralisation 
mimicked the chemical composition of ligament-to-bone interface. A 
reconstructive graft, moreover, needs to be fully integrated within the 
gradient hydrogel to resemble the chemical composition and mechanical 
performance of ligament tissue. Therefore, silk fabric as a ligament 
reconstruction graft was embedded within the gradient hydrogel and its 
physical integrity was qualified.  
6.10.2 Fabrication of Gradient Hybrid Hydrogel Embedded with Silk 
Fabric 
A gradient hydrogel embedded with silk fabric was fabricated based on the 
approach shown in Figure  6-13 with some modifications. The bioactive 
hydrogel with gradient of bioactive glass component was fabricated by 
transferring the mould to -20°C instead of photocrosslinking. The silk fabric 
was then settled on the top of physically crosslinked hydrogel and 
embedded with the secondary mould. The secondary layer of the gradient 
hydrogel was fabricated in the same method as shown in Figure  6-13. This 
complex was then transferred under UV light to form a gradient hydrogel 
embedded with silk fabric. 
The integrity of silk fabric within the gradient hydrogel was investigated by 
using SEM-EDS. The white arrows in Figure  6-15A indicated the presence 
of silk fabric in the gradient hydrogels. The monitoring of the silicon 
distribution in this construct, moreover, confirmed the successful integration 
of the electrospun film within the hydrogel. The dash-lines in Figure  6-15B 
showed the boarders of silk-tropoelastin fabric within the hydrogels, as no 
silica has been detected in this region.  
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Figure  6-15 SEM image (A) and the distribution of silicon (B) on the surface of the 
gradient hydrogel embedded with silk fabric. White arrows indicate to the electrospun 
film. Dash-lines in (B) represent to the boarders of silk fabric. Scale bars represent 
1mm. 
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6.11 Summary 
In this chapter, the feasibility of secondary crosslinking agent for enhancing 
the mechanical properties and degradation profile of hydrogels was 
examined. The favourable polymer for bioconjugation with hybrid hydrogel 
was PEGDA. The inert nature of this photocrosslinkable polymer and its 
high solubility in water led to the formation of bioconjugated hybrid 
hydrogel with tuneable mechanical strength and degradation profile. This 
polymer, moreover, did not interfere with organosilation and hybridisation 
of GelMA.  
The concentration of PEGDA was also optimised to acquire a hydrogel with 
enhanced mechanical stability and physical integrity over time compared to 
the covalently bonded GelMA-BG hybrid. The hydrogels fabricated from 
100 mg/ml Fn-GelMA, 100 mg/ml PEGDA and 0.5 µl TEOS solution per 
each milligram of the organic component had superior properties. The 
in vitro bioactivity and biological properties as well as in vivo 
biocompatibility and degradation profile of bioconjugated hybrid hydrogels 
were also examined. The precipitation of Ca-P particles on the surface of 
these hybrids enhanced the in vitro proliferation of osteoblasts and the 
secretion of bone-specific enzymes. 
The in vivo mice-subcutaneous implantation, moreover, confirmed the 
biocompatibility and bio-resorption of these hydrogels for bone tissue 
engineering. The feasible application of these hybrid hydrogels for interface 
tissue engineering was also investigated. The bioactive hydrogel with a 
gradient of mineralisation was fabricated from GelMA that was covalently 
bonded with bioactive glass. This gradient hydrogel could withstand the 
elongation loads without any deformation. These results demonstrated the 
potential of bioconjugated hybrid hydrogels for bone repair and engineering 
its interface with soft tissues. 
  
Chapter 7. Conclusions and 
Recommendations
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7.1 Conclusions 
The organic-inorganic hybrids fabricated by the sol-gel method are intrinsic 
bioactive materials with extensive applications in bone tissue engineering. 
The brittleness and limited water uptake capacity of these monoliths, 
however, restrict their applications for the interface of soft and hard tissues. 
The aim of this study was to develop a unique structure for reconstruction of 
bone structure and its interface with soft tissues. To this end, a new class of 
polymer-inorganic hybrid was developed in which polymer crosslinking 
ceased the over-condensation of a bioactive glass component and eradicated 
the formation of brittle structure.  
The feasibility of this approach was confirmed by formation of covalently 
bonded hybrid hydrogels of gelatin and BG upon the combination of sol-gel 
method, organosilation process, and polymer-crosslinking. To this end, 
GelMA was functionalised with GPTMS for chemical bonding to BG 
through sol-gel method. This organosilation reaction and hybrid formation 
did not interfere with crosslinking of the polymer phase. Prior to the 
complete condensation of BG, GelMA sessions were photocrosslinked to 
eradicate the formation of brittle structures. The formation of these hybrid 
hydrogels was governed by the external stimuli such as temperature and the 
isoelectric point of polymer and BG, the chemical structure of organosilane 
coupling agent, and the concentration of the inorganic component. The 
physicochemical properties and mechanical strength of these hybrid 
hydrogels were then tuned by the incorporation of secondary crosslinking 
agents such as PEGDA. The resulting biodegradable hydrogels displayed 
elastic properties with ultimate elastic compression strain above 
0.2 (mm/mm). Furthermore, the compression modulus of these hydrogels 
was tuned in the range of 42-530 kPa while they demonstrated the minimum 
swelling ratio of 400 %, which is still acceptable for tissue engineering 
applications. 
The regulation of mechanical properties and degradation profile is a key 
factor for in vivo performance of hydrogels in tissue engineering 
applications. The hybrid hydrogels were therefore incubated in simulated 
Page | 119 
 
body fluid to evaluate their in vitro degradation profiles, as well as their 
mechanical properties over time. The optimum hybrid hydrogel comprised 
from 100 mg/ml Fn-GelMA, 100 mg/ml PEGDA and hybridised with 0.5 µl 
of bioactive glass solution per each milligram of polymer content. This 
hybrid hydrogel kept its structure 28 days post-incubation and displayed 
elastic properties. The presence of homogeneously distributed bioactive 
glass in these hydrogels, moreover, promoted the precipitation of calcium 
phosphate particles as the main inorganic compositions of the bone 
extracellular matrix. The continuous increase of alkaline phosphatase 
activity of bone progenitor cells for at least 28 days in vitro cell culturing 
confirmed the osteoconductive properties of these hybrid hydrogels. The 
in vivo mice-subcutaneous implantation, moreover, confirmed the 
biocompatibility and bio-resorption of these hydrogels. These biological 
behaviours showed the potential of hybrid hydrogels for the regeneration of 
bone fractures. 
The chemical composition of ligament-to-bone interface was mimicked 
upon the fabrication of GelMA-based hydrogel with a gradient of covalently 
bonded bioactive glasses. This gradient hydrogel could withstand the 
elongation loads without any deformation. The feasibility of integration of a 
constructive graft was also evaluated by embedding a silk fabric within this 
gradient hydrogel. The results of this study confirmed that this bioactive 
scaffold had a great potential to engineer the interface of bone and soft 
tissues. 
7.2 Recommendations 
The main scope of this study was to develop a new approach to fabricating a 
non-brittle structure with a homogeneous distribution of inorganic 
compounds for regenerating the bone and its interface with soft tissues. The 
outcomes of this study broaden the application of organic-inorganic hybrids 
by controlling the over-condensation of the silica network via polymer 
crosslinking. This new class of hydrogels displayed tuneable 
physicochemical characteristics with superior structural integrity and 
remarkable bioactivity, cytocompatibility and bio-resorption properties.  
Page | 120 
 
The presence of photocrosslinkable polymer in this approach presents a 
great potential of these bioactive hybrids for in situ tissue engineering. The 
progenitor cells may suspend into a solution of organic-inorganic hybrid to 
form an injectable, cell-encapsulated hydrogel. Series of in vitro and in vivo 
studies need to be conducted to confirm the feasibility of cell-encapsulation 
with these hydrogels and their potential to maintain the metabolic activity 
for dental applications. 
The solubility of these materials provides a huge potential for fabrication of 
hybrid hydrogels via 3D printing and stereolithography. The presence of the 
inorganic compound may promote the angiogenic behaviour of the 
hydrogels. The biological motifs, therefore, can be encapsulated within the 
organic-inorganic hybrids to form a 3D hydrogel with predetermined 
topography. Series of in vitro studies need to be conducted to confirm the 
angiogenicity of these hydrogels and their potential to maintain the 
metabolic activity and to support the proliferation cells.  
The presence of a semi-conductive material (silica) in the hybrids may 
promote the electro-conductivity of these hydrogels. This class of hydrogels, 
therefore, is deemed to have a potential for nerve tissue engineering. Series 
of in vitro studies need to be conducted to confirm the feasibility of 
delivering neural stem cells with these hydrogels and their potential to 
maintain the metabolic activity and to support the proliferation cells.  
 
These gelatin-bioactive glass hybrid hydrogels can be used for mimicking 
the bone structure and its interface with soft tissues. However, further 
studies should be conducted to assess the potential of hybrid hydrogels for 
interface tissue engineering, systematically: 
 Co-culturing of ligament and bone progenitor cells on the gradient 
hydrogels. The potential of gradient hydrogels for mimicking the 
cellular constitution of ligament-to-bone interface needs to be fully 
assessed by simultaneous cultivation of fibroblast and osteoblast 
cells on the surface of gradient hydrogels to regenerate ligament and 
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bone sides, respectively. The cell proliferation and also migration of 
these progenitor cells on the gradient hydrogels need to be evaluated 
systematically. 
 Encapsulating of mesenchymal stem cells in gradient hydrogels in 
the presence of biological motifs. The feasibility of cell 
encapsulation within GelMA-based hydrogels has been confirmed 
and thus the hydrogels with a gradient of mineralisation may display 
a high potential for differentiation of MSC cells to form a gradient of 
the cellular constitution. The presence of biological motifs such as 
growth factor, moreover, significantly promoted the proliferation of 
MSC cells. An engineered ligament-to-bone interface with a gradient 
of chemical composition and cellular constitution, therefore, can be 
fabricated upon the encapsulation of MSC cells in the presence of 
growth factors. 
 Pilot in vivo animal studies on the potential of hybrid hydrogels for 
the regeneration of bone defects. The osteogenic properties of hybrid 
hydrogels have been confirmed and thus, gradient hydrogels may 
display a high potential for the regeneration of bone. Pig ligament-
to-bone defect can be used to promote the migration of progenitor 
cells from bone marrow to the defected site and regeneration of 
ligament enthesis.  
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Appendix A the precise amount of materials for synthesising of 
photocrosslinkable polymers and fabrication of various hydrogels 
 
 
Table 1 The accurate amount of materials for synthesis of GelMA* 
Material Polymeric solution Temperature 
(C) 
MA* solution Final Volume 
(ml) Mass 
(g) 
PBS* (ml) Mass 
(g) 
PBS 
(ml) 
Gelatin (Porcine) 10.625 87.5 50 1.51 20 600 (100+500) 
*GelMA: Gelatin-methacrylate; MA: Methacrylic anhydride; PBS: Phosphate Buffer Saline  
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Table 2 The accurate amount of materials for synthesis of StaMA* 
Material Polymeric 
solution 
Temperature 
(C) 
MA* solution NaOH 
solution 
Final 
Volume 
(ml) Mass 
(g) 
PBS* 
(ml) 
Mass 
(g) 
PBS 
(ml) 
Mass 
(g) 
PBS 
(mL) 
Starch 40 80 50 1.51 20 3 100 100 
*StaMA: Starch-Methacrylate; MA: Methacrylic anhydride; PBS: Phosphate Buffer Saline.  
  
Page | C 
 
Table 3 The accurate amount of materials for synthesis of BG* 
Material Bioactive glass 
precursor (ml) 
Distilled Water 
(ml) 
Hydrochloric acid 
(µl) 
Tetraethyl orthosilicate 
(TEOS) 
5.54 3.625 50 
Tetramethyl orthosilicate 
(TMOS) 
2 18 - 
*BG: Bioactive Glass 
  
Page | D 
 
Table 4 The precise amount of materials for fabrication of interpenetrated gelatin-BG hybrid hydrogels 
Hydrogel Gelatin 
(GelMA*) 
Genipin Irgacure BG* Final 
Volume 
(ml) Mass 
(mg) 
PBS* 
(ml) 
Mass 
(mg) 
PBS 
(ml) 
Mass 
(mg) 
PBS 
(ml) 
Ratio 
(µl/mg) 
Volume 
(ml) 
Gel_GP1 200 1.25 2.67 0.75 - - 0 0 2 
Gel_GP2.5 200 1.25 6.67 0.75 - - 0 0 2 
Gel_GP5 200 1.25 13.3 0.75 - - 0 0 2 
Gel_GP7.5 200 1.25 20 0.75 - - 0 0 2 
Hybrid_B1 200 1.0 6.25 0.8 - - 1 0.2 2 
Hybrid_B1.5 200 1.0 7.14 0.7 - - 1.5 0.3 2 
Hybrid_B2 200 1.0 8.3 0.6 - - 2 0.4 2 
Hybrid_B4 200 0.8 12.5 0.4 - - 4 0.8 2 
Hybrid_B6 200 0.5 16.7 0.3 - - 6 1.2 2 
GelMA 200 2 - - 6.67 0.3 0 0 2 
Gel-B0.5 200 1.6 - - 6.67 0.3 0.5 0.1 2 
Gel-B1 200 1.5 - - 6.67 0.3 1 0.2 2 
Gel-B2 200 1.3 - - 6.67 0.3 2 0.4 2 
*GelMA: Gelatin-Methacrylate; BG: Bioactive Glass (from Tetraethyl orthosilicate); PBS: 
Phosphate Buffer Saline.  
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Table 5 The precise amount of materials for fabrication of covalently-bonded Fn-GelMA-BG hybrid 
hydrogels 
Hydrogel GelMA* Irgacure GPTMS* 
(ml) 
BG* Final 
Volume 
(ml) 
Mass 
(mg) 
PBS* 
(ml) 
Mass 
(mg) 
PBS 
(ml) 
Ratio 
(µl/mg) 
Volume 
(ml) 
Gel_75 150 1.7 6.67 0.3 0 0 0 2 
Fn-Gel_75 150 1.686 6.67 0.3 0.014 0 0 2 
Fn-G75-B0.25 150 1.648 6.67 0.3 0.014 0.25 0.038 2 
Fn-G75-B0.5 150 1.611 6.67 0.3 0.014 0.5 0.075 2 
Fn-G75-B1 150 1.536 6.67 0.3 0.014 1 0.15 2 
Gel_100 200 1.7 6.67 0.3 0 0 0 2 
Fn-Gel_100 200 1.682 6.67 0.3 0.018 0 0 2 
Fn-G100-B0.25 200 1.632 6.67 0.3 0.018 0.25 0.05 2 
Fn-G100-B0.5 200 1.582 6.67 0.3 0.018 0.5 0.1 2 
Fn-G100-B1 200 1.482 6.67 0.3 0.018 1 0.2 2 
Gel_150 300 1.7 6.67 0.3 0 0 0 2 
Fn-Gel_150 300 1.672 6.67 0.3 0.028 0 0 2 
Fn-G150-B0.25 300 1.597 6.67 0.3 0.028 0.25 0.075 2 
Fn-G150-B0.5 300 1.522 6.67 0.3 0.028 0.5 0.15 2 
Fn-G150-B1 300 1.372 6.67 0.3 0.028 1 0.3 2 
*GelMA: Gelatin-Methacrylate; GPTMS: Glycidoxypropylene trimethoxysilane; BG: 
Bioactive Glass (from Tetraethyl orthosilicate); PBS: Phosphate Buffer Saline.  
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Table 6 The precise amount of materials for fabrication of conjugated Fn-GelMA-StaMA-BG hybrid 
hydrogels 
Hydrogel Organic Content Irgacure GPTMS* 
(ml) 
BG* Final 
Volume 
(ml) 
GelMA* 
(mg) 
StaMA* 
(mg) 
PBS* 
(ml) 
Mass 
(mg) 
PBS 
(ml) 
Ratio 
(µl/mg) 
Volume 
(ml) 
Gel 200 0 1.7 6.67 0.3 0 0 0 2 
Fn-Gel-
BG 
200 0 1.582 6.67 0.3 0.018 0.5 0.1 2 
Gel-Sta 200 40 1.7 6.67 0.3 0 0 0 2 
Fn-Gel-
Sta-BG 
200 40 1.562 6.67 0.3 0.018 0.5 0.12 2 
*GelMA: Gelatin-Methacrylate; StaMA: Starch-Methacrylate; GPTMS: 
Glycidoxypropylene trimethoxysilane; BG: Bioactive Glass (from Tetraethyl orthosilicate); 
PBS: Phosphate Buffer Saline.  
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Table 7 The precise amount of materials for fabrication of conjugated Fn-GelMA-PEGDA-BG hybrid  
Hydrogel Organic Content Irgacure GPTMS* 
(ml) 
BG* Final 
Volume 
(ml) 
GelMA* 
(mg) 
PEGDA* 
(mg) 
PBS* 
(ml) 
Mass 
(mg) 
PBS 
(ml) 
Ratio 
(µl/mg) 
Volume 
(ml) 
Gel 200 0 1.7 6.67 0.3 0 0 0 2 
Gel-P50 200 100 1.7 6.67 0.3 0 0 0 2 
Gel-P100 200 200 1.7 6.67 0.3 0 0 0 2 
Gel-P150 200 300 1.7 6.67 0.3 0 0 0 2 
Gel-P200 200 400 1.7 6.67 0.3 0 0 0 2 
Fn-Gel-
BG 
200 0 1.582 6.67 0.3 0.018 0.5 0.1 2 
Fn-Gel-
P50-BG 
200 100 1.532 6.67 0.3 0.018 0.5 0.15 2 
Fn-Gel-
P100-BG 
200 200 1.482 6.67 0.3 0.018 0.5 0.2 2 
*GelMA: Gelatin-Methacrylate; PEGDA: Poly(ethylene glycol diacrylate); GPTMS: 
Glycidoxypropylene trimethoxysilane; BG: Bioactive Glass (from Tetraethyl orthosilicate); 
PBS: Phosphate Buffer Saline.  
 
